| Year |
Citation |
Score |
| 2024 |
Zeng L, Atlas K, Lama T, Chitnis T, Weiner H, Wang G, Fujita M, Zipp F, Taga M, Kiryluk K, De Jager PL. GWAS highlights the neuronal contribution to multiple sclerosis susceptibility. Medrxiv : the Preprint Server For Health Sciences. PMID 39677438 DOI: 10.1101/2024.12.04.24318500 |
0.367 |
|
| 2024 |
Madill E, Healy BC, Molazadeh N, Polgar-Turcsanyi M, Glanz BI, Weiner HL, Chitnis T. Serum glial fibrillary acidic protein predicts disease progression in multiple sclerosis. Annals of Clinical and Translational Neurology. PMID 39238198 DOI: 10.1002/acn3.52187 |
0.381 |
|
| 2024 |
Saucier L, Healy BC, Saxena S, Sanon E, Chitnis T. Glial fibrillary acidic protein and neurofilament light chain as biomarkers in pediatric multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 10: 20552173241274567. PMID 39193071 DOI: 10.1177/20552173241274567 |
0.303 |
|
| 2024 |
Jensen SKG, Camposano S, Berens A, Waltz M, Krupp LB, Charvet L, Belman AL, Aaen GS, Benson LA, Candee M, Casper TC, Chitnis T, Graves J, Wheeler YS, Kahn I, et al. Early Adversity and Socioeconomic Factors in Pediatric Multiple Sclerosis: A Case-Control Study. Neurology(R) Neuroimmunology & Neuroinflammation. 11: e200282. PMID 39146511 DOI: 10.1212/NXI.0000000000200282 |
0.388 |
|
| 2024 |
Mohan SD, Peterson S, Brenton JN, Carmichael SL, Virupakshaiah A, Rodriguez M, Tillema JM, Mar S, Rensel MR, Abrams A, Chitnis T, Benson L, Gorman M, Lotze T, Shukla N, et al. Association of nutritional intake with clinical and imaging activity in pediatric multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 30: 1056-1065. PMID 39078111 DOI: 10.1177/13524585241261556 |
0.374 |
|
| 2024 |
Manzano GS, Levy M, Salky R, Mateen FJ, Klawiter EC, Chitnis T, Vasileiou ES, Sotirchos ES, Gibbons E, Huda S, Jacob A, Matiello M. Assessment of international MOGAD diagnostic criteria in patients with overlapping MOG-associated disease and multiple sclerosis phenotypes. Journal of Neurology. PMID 39066792 DOI: 10.1007/s00415-024-12585-w |
0.369 |
|
| 2024 |
Nasr Z, Casper TC, Waltz M, Virupakshaiah A, Lotze T, Shukla N, Chitnis T, Gorman M, Benson LA, Rodriguez M, Tillema JM, Krupp L, Schreiner T, Mar S, Rensel M, et al. Clinical and magnetic resonance imaging outcomes in pediatric-onset MS patients on fingolimod and ocrelizumab. Multiple Sclerosis and Related Disorders. 87: 105647. PMID 38838422 DOI: 10.1016/j.msard.2024.105647 |
0.319 |
|
| 2024 |
Chitnis T, Qureshi F, Gehman VM, Becich M, Bove R, Cree BAC, Gomez R, Hauser SL, Henry RG, Katrib A, Lokhande H, Paul A, Caillier SJ, Santaniello A, Sattarnezhad N, et al. Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis. Nature Communications. 15: 4297. PMID 38769309 DOI: 10.1038/s41467-024-48602-9 |
0.342 |
|
| 2024 |
Airas L, Bermel RA, Chitnis T, Hartung HP, Nakahara J, Stuve O, Williams MJ, Kieseier BC, Wiendl H. A review of Bruton's tyrosine kinase inhibitors in multiple sclerosis. Therapeutic Advances in Neurological Disorders. 17: 17562864241233041. PMID 38638671 DOI: 10.1177/17562864241233041 |
0.336 |
|
| 2024 |
Singhal T, Cicero S, Rissanen E, Ficke J, Kukreja P, Vaquerano S, Glanz B, Dubey S, Sticka W, Seaver K, Kijewski M, Callen AM, Chu R, Carter K, Silbersweig D, ... Chitnis T, et al. Glial Activity Load on PET Reveals Persistent "Smoldering" Inflammation in MS Despite Disease-Modifying Treatment: 18F-PBR06 Study. Clinical Nuclear Medicine. PMID 38630948 DOI: 10.1097/RLU.0000000000005201 |
0.33 |
|
| 2024 |
Ziaei A, Solomon O, Casper TC, Waltz M, Weinstock-Guttman B, Aaen G, Wheeler Y, Graves J, Benson L, Gorman M, Rensel M, Mar S, Lotze T, Greenberg B, Chitnis T, et al. Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231224685. PMID 38332747 DOI: 10.1177/13524585231224685 |
0.311 |
|
| 2023 |
Rutatangwa A, Aaen G, Krysko KM, Belman A, Benson LA, Chitnis T, Gorman M, Goyal M, Graves JS, Wheeler Y, Krupp L, Lotze T, Mar S, Ness J, Rensel M, et al. Characteristics and predictors of disease course in children initially presenting with ADEM. Multiple Sclerosis and Related Disorders. 80: 105075. PMID 39491412 DOI: 10.1016/j.msard.2023.105075 |
0.325 |
|
| 2023 |
Ontaneda D, Chitnis T, Rammohan K, Obeidat AZ. Identification and management of subclinical disease activity in early multiple sclerosis: a review. Journal of Neurology. PMID 37864717 DOI: 10.1007/s00415-023-12021-5 |
0.395 |
|
| 2023 |
Bose G, Healy BC, Saxena S, Saleh F, Glanz BI, Bakshi R, Weiner HL, Chitnis T. Increasing Neurofilament and Glial Fibrillary Acidic Protein After Treatment Discontinuation Predicts Multiple Sclerosis Disease Activity. Neurology(R) Neuroimmunology & Neuroinflammation. 10. PMID 37813595 DOI: 10.1212/NXI.0000000000200167 |
0.323 |
|
| 2023 |
Chitnis T. Navigating the challenges of diagnosing multiple sclerosis. The Lancet. Neurology. 22: 649-651. PMID 37479366 DOI: 10.1016/S1474-4422(23)00243-0 |
0.382 |
|
| 2023 |
Chitnis T, Qureshi F, Gehman VM, Becich M, Bove R, Cree BAC, Gomez R, Hauser SL, Henry RG, Katrib A, Lokhande H, Paul A, Caillier SJ, Santaniello A, Sattarnezhad N, et al. Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosis. Medrxiv : the Preprint Server For Health Sciences. PMID 37461671 DOI: 10.1101/2023.06.28.23291157 |
0.371 |
|
| 2023 |
Malani Shukla N, Casper TC, Ness J, Wheeler Y, Chitnis T, Lotze T, Gorman M, Benson L, Weinstock-Guttmann B, Aaen G, Rodriguez M, Tillema JM, Krupp L, Schreiner T, Mar S, et al. Demographic Features and Clinical Course of Patients With Pediatric-Onset Multiple Sclerosis on Newer Disease-Modifying Treatments. Pediatric Neurology. 145: 125-131. PMID 37348193 DOI: 10.1016/j.pediatrneurol.2023.04.020 |
0.402 |
|
| 2023 |
Hobart J, Chitnis T, Oh J, Burke L, King M, Vo P, Vandercappellen J, Lloyd A. Do clinical trials prepare to fail by failing to prepare? An examination of MS trials and recommendations for patient-reported outcome measure selection. Multiple Sclerosis and Related Disorders. 76: 104788. PMID 37327599 DOI: 10.1016/j.msard.2023.104788 |
0.305 |
|
| 2023 |
Gonzalez-Martinez A, Bose G, Lokhande H, Saxena S, Healy BC, Polgar-Turcsanyi M, Weiner HL, Chitnis T. Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort study. Journal of Neuroinflammation. 20: 136. PMID 37264432 DOI: 10.1186/s12974-023-02816-8 |
0.319 |
|
| 2023 |
Gonzalez-Martinez A, Patel R, Healy BC, Lokhande H, Paul A, Saxena S, Polgar-Turcsanyi M, Weiner HL, Chitnis T. miRNA 548a-3p as biomarker of NEDA-3 at 2 years in multiple sclerosis patients treated with fingolimod. Journal of Neuroinflammation. 20: 131. PMID 37254147 DOI: 10.1186/s12974-023-02811-z |
0.305 |
|
| 2023 |
Horton MK, Shim JE, Wallace A, Graves JS, Aaen G, Greenberg B, Mar S, Wheeler Y, Weinstock-Guttman B, Waldman A, Schreiner T, Rodriguez M, Tillema JM, Chitnis T, Krupp L, et al. Rare and low-frequency coding genetic variants contribute to pediatric-onset multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221150736. PMID 36755464 DOI: 10.1177/13524585221150736 |
0.323 |
|
| 2023 |
Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, Ramanathan S, Waters P, Tenembaum S, Graves JS, Chitnis T, Brandt AU, Hemingway C, Neuteboom R, Pandit L, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. The Lancet. Neurology. PMID 36706773 DOI: 10.1016/S1474-4422(22)00431-8 |
0.312 |
|
| 2022 |
Beecham AH, Amezcua L, Chinea A, Manrique CP, Gomez L, Martinez A, Beecham GW, Patsopoulos NA, Chitnis T, Weiner HL, De Jager PL, Burchard EG, Lund BT, Fitzgerald KC, Calabresi PA, et al. Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population. Plos One. 17: e0279132. PMID 36548255 DOI: 10.1371/journal.pone.0279132 |
0.307 |
|
| 2022 |
Chitnis T. Multiple sclerosis in 2022: old players, new insights. The Lancet. Neurology. 22: 19-21. PMID 36517159 DOI: 10.1016/S1474-4422(22)00479-3 |
0.308 |
|
| 2022 |
Ziemssen T, Bhan V, Chataway J, Chitnis T, Campbell Cree BA, Havrdova EK, Kappos L, Labauge P, Miller A, Nakahara J, Oreja-Guevara C, Palace J, Singer B, Trojano M, Patil A, et al. Secondary Progressive Multiple Sclerosis: A Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying Therapies. Neurology(R) Neuroimmunology & Neuroinflammation. 10. PMID 36414428 DOI: 10.1212/NXI.0000000000200064 |
0.363 |
|
| 2022 |
Barro C, Healy BC, Liu Y, Saxena S, Paul A, Polgar-Turcsanyi M, Guttmann CRG, Bakshi R, Kropshofer H, Weiner HL, Chitnis T. Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis. Neurology(R) Neuroimmunology & Neuroinflammation. 10. PMID 36376097 DOI: 10.1212/NXI.0000000000200052 |
0.411 |
|
| 2022 |
Bose G, Healy BC, Barro C, Glanz BI, Lokhande HA, Polgar-Turcsanyi M, Guttmann CR, Bakshi R, Weiner HL, Chitnis T. Younger age at multiple sclerosis onset is associated with worse outcomes at age 50. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 35953266 DOI: 10.1136/jnnp-2022-329353 |
0.32 |
|
| 2022 |
Holroyd KB, Healy BC, Conway S, Houtchens M, Bakshi R, Bhattacharyya S, Bose G, Galetta K, Kaplan T, Severson C, Singhal T, Stazzone L, Zurawski J, Polgar-Turcsanyi M, Saxena S, ... ... Chitnis T, et al. Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes. Multiple Sclerosis and Related Disorders. 67: 104079. PMID 35952457 DOI: 10.1016/j.msard.2022.104079 |
0.302 |
|
| 2022 |
Sattarnezhad N, Healy BC, Baharnoori M, Diaz-Cruz C, Stankiewicz J, Weiner HL, Chitnis T. Comparison of dimethyl fumarate and interferon outcomes in an MS cohort. Bmc Neurology. 22: 252. PMID 35820822 DOI: 10.1186/s12883-022-02761-8 |
0.363 |
|
| 2022 |
Bharadia T, Vandercappellen J, Chitnis T, Eelen P, Bauer B, Brichetto G, Lloyd A, Schmidt H, King M, Fitzgerald J, Hach T, Hobart J. Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables? Multiple Sclerosis Journal - Experimental, Translational and Clinical. 8: 20552173221105642. PMID 35755007 DOI: 10.1177/20552173221105642 |
0.362 |
|
| 2022 |
Conway SE, Healy BC, Zurawski J, Severson C, Kaplan T, Stazzone L, Galetta K, Chitnis T, Houtchens MK. COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders. Multiple Sclerosis and Related Disorders. 63: 103946. PMID 35709663 DOI: 10.1016/j.msard.2022.103946 |
0.311 |
|
| 2022 |
Guo MH, Sama P, LaBarre BA, Lokhande H, Balibalos J, Chu C, Du X, Kheradpour P, Kim CC, Oniskey T, Snyder T, Soghoian DZ, Weiner HL, Chitnis T, Patsopoulos NA. Dissection of multiple sclerosis genetics identifies B and CD4+ T cells as driver cell subsets. Genome Biology. 23: 127. PMID 35672799 DOI: 10.1186/s13059-022-02694-y |
0.321 |
|
| 2022 |
Chitnis T, Weiner HL. Targeting Epstein-Barr virus to treat MS. Med (New York, N.Y.). 3: 159-161. PMID 35590190 DOI: 10.1016/j.medj.2022.02.005 |
0.336 |
|
| 2022 |
Kaplan TB, Gopal A, Block VJ, Suskind AM, Zhao C, Polgar-Turcsanyi M, Saraceno TJ, Gomez R, Santaniello A, Consortium S, Ayoubi NE, Cree BAC, Hauser SL, Weiner H, Chitnis T, et al. Challenges to Longitudinal Characterization of Lower Urinary Tract Dysfunction in Multiple Sclerosis. Multiple Sclerosis and Related Disorders. 62: 103793. PMID 35461057 DOI: 10.1016/j.msard.2022.103793 |
0.371 |
|
| 2022 |
Bose G, Healy BC, Lokhande HA, Sotiropoulos MG, Polgar-Turcsanyi M, Anderson M, Glanz BI, Guttman CRG, Bakshi R, Weiner HL, Chitnis T. Early predictors of clinical and MRI outcomes using LASSO in multiple sclerosis. Annals of Neurology. PMID 35429009 DOI: 10.1002/ana.26370 |
0.361 |
|
| 2022 |
Hardy D, Chitnis T, Waubant E, Banwell B. Preventing Multiple Sclerosis: The Pediatric Perspective. Frontiers in Neurology. 13: 802380. PMID 35280298 DOI: 10.3389/fneur.2022.802380 |
0.438 |
|
| 2022 |
Lublin FD, Häring DA, Ganjgahi H, Ocampo A, Hatami F, Čuklina J, Aarden P, Dahlke F, Arnold DL, Wiendl H, Chitnis T, Nichols TE, Kieseier BC, Bermel RA. How patients with multiple sclerosis acquire disability. Brain : a Journal of Neurology. PMID 35104840 DOI: 10.1093/brain/awac016 |
0.415 |
|
| 2022 |
Lokhande H, Rosso M, Tauhid S, Chu R, Healy BC, Saxena S, Barro C, Paul A, Polgar-Turcsanyi M, Anderson M, Glanz BI, Kropshofer H, Granziera C, Leppert D, Kappos L, ... ... Chitnis T, et al. Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MS. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 8: 20552173211069348. PMID 35035990 DOI: 10.1177/20552173211069348 |
0.37 |
|
| 2022 |
Sebastian P, Cherbuin N, Barcellos LF, Roalstad S, Casper C, Hart J, Aaen GS, Krupp L, Benson L, Gorman M, Candee M, Chitnis T, Goyal M, Greenberg B, Mar S, et al. Association Between Time Spent Outdoors and Risk of Multiple Sclerosis. Neurology. 98: e267-e278. PMID 34880094 DOI: 10.1212/WNL.0000000000013045 |
0.31 |
|
| 2021 |
Liang L, Kim N, Hou J, Cai T, Dahal K, Lin C, Finan S, Savovoa G, Rosso M, Polgar-Tucsanyi M, Weiner H, Chitnis T, Cai T, Xia Z. Temporal trends of multiple sclerosis disease activity: Electronic health records indicators. Multiple Sclerosis and Related Disorders. 57: 103333. PMID 35158446 DOI: 10.1016/j.msard.2021.103333 |
0.356 |
|
| 2021 |
Chitnis T, Banwell B, Kappos L, Arnold DL, Gücüyener K, Deiva K, Skripchenko N, Cui LY, Saubadu S, Hu W, Benamor M, Le-Halpere A, Truffinet P, Tardieu M. Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial. The Lancet. Neurology. 20: 1001-1011. PMID 34800398 DOI: 10.1016/S1474-4422(21)00364-1 |
0.304 |
|
| 2021 |
Healy BC, Zurawski J, Chitnis T, Weiner HL, Glanz BI. Patient-reported outcomes associated with transition to secondary progressive multiple sclerosis. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 34783972 DOI: 10.1007/s11136-021-03034-6 |
0.324 |
|
| 2021 |
Hou J, Kim N, Cai T, Dahal K, Weiner H, Chitnis T, Cai T, Xia Z. Comparison of Dimethyl Fumarate vs Fingolimod and Rituximab vs Natalizumab for Treatment of Multiple Sclerosis. Jama Network Open. 4: e2134627. PMID 34783826 DOI: 10.1001/jamanetworkopen.2021.34627 |
0.303 |
|
| 2021 |
Baharnoori M, Wilson R, Saxena S, Gonzalez CT, Sotiropoulos MG, Keyhanian K, Healy BC, Chitnis T. Altered adipokine levels are associated with dimethyl fumarate treatment in multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 56: 103311. PMID 34655958 DOI: 10.1016/j.msard.2021.103311 |
0.365 |
|
| 2021 |
Sandesjö F, Wassmer E, Deiva K, Amato MP, Chitnis T, Hemingway C, Krupp L, Pohl D, Rostasy K, Waubant E, Banwell B, Wickström R. Current international trends in the treatment of multiple sclerosis in children-Impact of the COVID-19 pandemic. Multiple Sclerosis and Related Disorders. 56: 103277. PMID 34624643 DOI: 10.1016/j.msard.2021.103277 |
0.374 |
|
| 2021 |
Mandel LA, O'Donnell E, Canenguez K, Castro-Mendoza PB, Lotze T, Waubant E, Weinstock-Guttmann B, Chitnis T. Family Perspectives on Clinical Research for Pediatric Multiple Sclerosis: Enhancing Equity. Journal of Patient Experience. 8: 23743735211039319. PMID 34541304 DOI: 10.1177/23743735211039319 |
0.323 |
|
| 2021 |
Greenberg BM, Casper TC, Mar SS, Ness JM, Plumb P, Liang S, Goyal M, Weinstock-Guttman B, Rodriguez M, Aaen GS, Belman A, Barcellos LF, Rose JW, Gorman MP, Benson LA, ... ... Chitnis T, et al. Familial History of Autoimmune Disorders Among Patients With Pediatric Multiple Sclerosis. Neurology(R) Neuroimmunology & Neuroinflammation. 8. PMID 34353894 DOI: 10.1212/NXI.0000000000001049 |
0.339 |
|
| 2021 |
Barro C, Paul A, Saleh F, Chitnis T, Weiner HL. Validation of Two Kinetic Assays for the Quantification of Endotoxin in Human Serum. Frontiers in Neurology. 12: 691683. PMID 34248828 DOI: 10.3389/fneur.2021.691683 |
0.311 |
|
| 2021 |
Sotiropoulos MG, Lokhande H, Healy BC, Polgar-Turcsanyi M, Glanz BI, Bakshi R, Weiner HL, Chitnis T. Relapse recovery in multiple sclerosis: Effect of treatment and contribution to long-term disability. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 7: 20552173211015503. PMID 34104471 DOI: 10.1177/20552173211015503 |
0.346 |
|
| 2021 |
Campbell Cree BA, Arnold DL, Chataway J, Chitnis T, Fox RJ, Ramajo AP, Murphy N, Lassmann H. Secondary Progressive Multiple Sclerosis: New Insights. Neurology. PMID 34088878 DOI: 10.1212/WNL.0000000000012323 |
0.442 |
|
| 2021 |
Glanz BI, Zurawski J, Casady EC, Shamah R, Weiner M, Chitnis T, Weiner HL, Healy BC. The impact of ocrelizumab on health-related quality of life in individuals with multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 7: 20552173211007523. PMID 34046184 DOI: 10.1177/20552173211007523 |
0.367 |
|
| 2021 |
Healy BC, Glanz BI, Swallow E, Signorovitch J, Hagan K, Silva D, Pelletier C, Chitnis T, Weiner H. Confirmed disability progression provides limited predictive information regarding future disease progression in multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 7: 2055217321999070. PMID 33953937 DOI: 10.1177/2055217321999070 |
0.36 |
|
| 2021 |
Cox LM, Maghzi AH, Liu S, Tankou SK, Dhang FH, Willocq V, Song A, Wasén C, Tauhid S, Chu R, Anderson MC, De Jager PL, Polgar-Turcsanyi M, Healy BC, Glanz BI, ... ... Chitnis T, et al. The Gut Microbiome in Progressive Multiple Sclerosis. Annals of Neurology. PMID 33876477 DOI: 10.1002/ana.26084 |
0.453 |
|
| 2021 |
Cortese M, Bjornevik K, Chitnis T, Ascherio A, Munger KL. Aging with multiple sclerosis: A longitudinal study of physical function, mental health, and memory in two cohorts of US women. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211007739. PMID 33860717 DOI: 10.1177/13524585211007739 |
0.311 |
|
| 2021 |
Ahuja Y, Kim N, Liang L, Cai T, Dahal K, Seyok T, Lin C, Finan S, Liao K, Savovoa G, Chitnis T, Cai T, Xia Z. Leveraging electronic health records data to predict multiple sclerosis disease activity. Annals of Clinical and Translational Neurology. PMID 33626237 DOI: 10.1002/acn3.51324 |
0.32 |
|
| 2021 |
Palotai M, Small C, Makris N, Somes NG, Pinzon AM, Rathi Y, Marzullo A, Levitt JJ, Bakshi R, Chitnis T, Guttmann CRG. Microstructural Changes in the Left Mesocorticolimbic Pathway are Associated with the Comorbid Development of Fatigue and Depression in Multiple Sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 33522683 DOI: 10.1111/jon.12832 |
0.332 |
|
| 2021 |
Galetta K, Deshpande C, Healy BC, Glanz B, Ziehn M, Saxena S, Paul A, Saleh F, Collins M, Gaitan-Walsh P, Castro-Mendoza P, Weiner HL, Chitnis T. Serum neurofilament levels and patient-reported outcomes in multiple sclerosis. Annals of Clinical and Translational Neurology. PMID 33492760 DOI: 10.1002/acn3.51305 |
0.379 |
|
| 2021 |
Fadda G, Armangue T, Hacohen Y, Chitnis T, Banwell B. Paediatric multiple sclerosis and antibody-associated demyelination: clinical, imaging, and biological considerations for diagnosis and care. The Lancet. Neurology. 20: 136-149. PMID 33484648 DOI: 10.1016/S1474-4422(20)30432-4 |
0.319 |
|
| 2021 |
Rosso M, Healy BC, Saxena S, Paul A, Bjornevik K, Kuhle J, Benkert P, Leppert D, Guttmann C, Bakshi R, Weiner HL, Chitnis T. MRI Lesion State Modulates the Relationship Between Serum Neurofilament Light and Age in Multiple Sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 33476489 DOI: 10.1111/jon.12826 |
0.349 |
|
| 2020 |
Zhao Y, Wang T, Bove R, Cree B, Henry R, Lokhande H, Polgar-Turcsanyi M, Anderson M, Bakshi R, Weiner HL, Chitnis T. Ensemble learning predicts multiple sclerosis disease course in the SUMMIT study. Npj Digital Medicine. 3: 135. PMID 33737720 DOI: 10.1038/s41746-020-00338-8 |
0.307 |
|
| 2020 |
Boesen MS, Blinkenberg M, Born AP, Magyari M, Chitnis T, Thygesen LC, Langkilde AR. Magnetic resonance imaging at baseline and follow-up to differentiate between pediatric monophasic acquired CNS demyelination and MS. Multiple Sclerosis and Related Disorders. 46: 102590. PMID 33296986 DOI: 10.1016/j.msard.2020.102590 |
0.385 |
|
| 2020 |
Zhao Y, Wang T, Bove R, Cree B, Henry R, Lokhande H, Polgar-Turcsanyi M, Anderson M, Bakshi R, Weiner HL, Chitnis T. Ensemble learning predicts multiple sclerosis disease course in the SUMMIT study. Npj Digital Medicine. 3: 135. PMID 33083570 DOI: 10.1038/s41746-020-00338-8 |
0.306 |
|
| 2020 |
Houtchens M, Bove R, Healy B, Houtchens S, Kaplan TB, Mahlanza T, Chitnis T, Bakshi R. MRI activity in MS and completed pregnancy: Data from a tertiary academic center. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 32917773 DOI: 10.1212/Nxi.0000000000000890 |
0.471 |
|
| 2020 |
Zhang T, Goodman M, Zhu F, Healy B, Carruthers R, Chitnis T, Weiner H, Cai T, De Jager P, Tremlett H, Xia Z. Phenome-wide examination of comorbidity burden and multiple sclerosis disease severity. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 32817202 DOI: 10.1212/Nxi.0000000000000864 |
0.515 |
|
| 2020 |
Chitnis T, Aaen G, Belman A, Benson L, Gorman M, Goyal MS, Graves JS, Harris Y, Krupp L, Lotze T, Mar S, Ness J, Rensel M, Schreiner T, Tillema JM, et al. Improved relapse recovery in paediatric compared to adult multiple sclerosis. Brain : a Journal of Neurology. PMID 32810215 DOI: 10.1093/Brain/Awaa199 |
0.443 |
|
| 2020 |
Saxena S, Lokhande H, Gombolay G, Raheja R, Rooney T, Chitnis T. Identification of TNFAIP3 as relapse biomarker and potential therapeutic target for MOG antibody associated diseases. Scientific Reports. 10: 12405. PMID 32709905 DOI: 10.1038/S41598-020-69182-W |
0.382 |
|
| 2020 |
Santoro JD, Waltz M, Aaen G, Belman A, Benson L, Gorman M, Goyal MS, Graves JS, Harris Y, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Rensel M, ... ... Chitnis T, et al. ediatric Multiple Sclerosis Severity Score in a Large U.S. Cohort. Neurology. PMID 32690790 DOI: 10.1212/Wnl.0000000000010414 |
0.485 |
|
| 2020 |
Chitnis T, Banwell B, Krupp L, Arnold DL, Bar-Or A, Brück W, Giovannoni G, Greenberg B, Ghezzi A, Waubant E, Rostasy K, Deiva K, Huppke P, Wolinsky JS, Zhang Y, et al. Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy in paediatric patients with multiple sclerosis: Results from the PARADIG study. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520936934. PMID 32633694 DOI: 10.1177/1352458520936934 |
0.363 |
|
| 2020 |
Ghezzi A, Banwell B, Bar-Or A, Chitnis T, Dale RC, Gorman M, Kornek B, Krupp L, Krysko KM, Nosadini M, Rostasy K, Salzer J, Schreiner T, Tenembaum S, Waubant E. Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520932798. PMID 32552353 DOI: 10.1177/1352458520932798 |
0.386 |
|
| 2020 |
Rosso M, Fremion E, Santoro SL, Oreskovic NM, Chitnis T, Skotko BG, Santoro JD. Down Syndrome Disintegrative Disorder: A Clinical Regression Syndrome of Increasing Importance. Pediatrics. 145. PMID 32471843 DOI: 10.1542/Peds.2019-2939 |
0.319 |
|
| 2020 |
Rosso M, Gonzalez CT, Healy BC, Saxena S, Paul A, Bjornevik K, Kuhle J, Benkert P, Leppert D, Guttmann C, Bakshi R, Weiner HL, Chitnis T. Temporal association of sNfL and gad-enhancing lesions in multiple sclerosis. Annals of Clinical and Translational Neurology. PMID 32452160 DOI: 10.1002/Acn3.51060 |
0.477 |
|
| 2020 |
Krysko KM, Graves JS, Rensel M, Weinstock-Guttman B, Rutatangwa A, Aaen G, Belman A, Benson L, Chitnis T, Gorman M, Goyal MS, Harris Y, Krupp L, Lotze T, Mar S, et al. Real-world effectiveness of initial disease-modifying therapies in pediatric MS. Annals of Neurology. PMID 32267005 DOI: 10.1002/Ana.25737 |
0.471 |
|
| 2020 |
Healy BC, Barker L, Bakshi R, Benedict RHB, Gonzalez CT, Chitnis T, Weiner HL, Glanz BI. Trajectories of Symbol Digit Modalities Test performance in individuals with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520913439. PMID 32228283 DOI: 10.1177/1352458520913439 |
0.327 |
|
| 2020 |
Arnold DL, Banwell B, Bar-Or A, Ghezzi A, Greenberg BM, Waubant E, Giovannoni G, Wolinsky JS, Gärtner J, Rostásy K, Krupp L, Tardieu M, Brück W, Stites TE, Pearce GL, ... ... Chitnis T, et al. Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIG study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32132224 DOI: 10.1136/Jnnp-2019-322138 |
0.35 |
|
| 2020 |
Mao-Draayer Y, Thiel S, Mills EA, Chitnis T, Fabian M, Katz Sand I, Leite MI, Jarius S, Hellwig K. Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations. Nature Reviews. Neurology. PMID 32080393 DOI: 10.1038/S41582-020-0313-Y |
0.321 |
|
| 2020 |
Mahlanza TD, Manieri MC, Klawiter EC, Solomon AJ, Lathi E, Ionete C, Berriosmorales I, Severson C, Stankiewicz J, Cabot A, Elkort M, Chitnis T, Bove R, Katz J, Houtchens M. Prospective growth and developmental outcomes in infants born to mothers with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520904545. PMID 32065561 DOI: 10.1177/1352458520904545 |
0.407 |
|
| 2020 |
Glanz BI, Zurawski J, Gonzalez CT, Shamah R, Ratajska A, Chitnis T, Weiner HL, Healy BC. Comparison of health-related quality of life across treatment groups in individuals with multiple sclerosis. Multiple Sclerosis and Related Disorders. 40: 101944. PMID 32007653 DOI: 10.1016/J.Msard.2020.101944 |
0.466 |
|
| 2020 |
Chitnis T, Prat A. A roadmap to precision medicine for multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519881558. PMID 31965904 DOI: 10.1177/1352458519881558 |
0.528 |
|
| 2020 |
Palotai M, Weiner HL, Chitnis T, Duffy JF, Guttmann CR. 1128 Sleep Apnea and Periodic Limb Movements are Highly Prevalent in Patients With Multiple Sclerosis Sleep. 43: A429-A430. DOI: 10.1093/Sleep/Zsaa056.1122 |
0.334 |
|
| 2019 |
Chitnis T, Glanz BI, Gonzalez C, Healy BC, Saraceno TJ, Sattarnezhad N, Diaz-Cruz C, Polgar-Turcsanyi M, Tummala S, Bakshi R, Bajaj VS, Ben-Shimol D, Bikhchandani N, Blocker AW, Burkart J, et al. Quantifying neurologic disease using biosensor measurements in-clinic and in free-living settings in multiple sclerosis. Npj Digital Medicine. 2: 123. PMID 33299125 DOI: 10.1038/s41746-019-0197-7 |
0.367 |
|
| 2019 |
Rosso M, Chitnis T. Association Between Cigarette Smoking and Multiple Sclerosis: A Review. Jama Neurology. PMID 31841592 DOI: 10.1001/Jamaneurol.2019.4271 |
0.365 |
|
| 2019 |
Chitnis T, Glanz BI, Gonzalez C, Healy BC, Saraceno TJ, Sattarnezhad N, Diaz-Cruz C, Polgar-Turcsanyi M, Tummala S, Bakshi R, Bajaj VS, Ben-Shimol D, Bikhchandani N, Blocker AW, Burkart J, et al. Quantifying neurologic disease using biosensor measurements in-clinic and in free-living settings in multiple sclerosis. Npj Digital Medicine. 2: 123. PMID 31840094 DOI: 10.1038/s41746-019-0197-7 |
0.367 |
|
| 2019 |
Wallach AI, Waltz M, Casper TC, Aaen G, Belman A, Benson L, Chitnis T, Gorman M, Graves J, Harris Y, Lotze TE, Mar S, Moodley M, Ness JM, Rensel M, et al. Cognitive processing speed in pediatric-onset multiple sclerosis: Baseline characteristics of impairment and prediction of decline. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519891984. PMID 31775571 DOI: 10.1177/1352458519891984 |
0.315 |
|
| 2019 |
Chitnis T. Serum NFL levels should be used to monitor multiple sclerosis evolution - Commentary. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519880471. PMID 31625830 DOI: 10.1177/1352458519880471 |
0.38 |
|
| 2019 |
Palotai M, Nazeri A, Cavallari M, Healy BC, Glanz B, Gold SM, Weiner HL, Chitnis T, Guttmann CRG. History of fatigue in multiple sclerosis is associated with grey matter atrophy. Scientific Reports. 9: 14781. PMID 31611598 DOI: 10.1038/S41598-019-51110-2 |
0.361 |
|
| 2019 |
Keyhanian K, Saxena S, Gombolay G, Healy BC, Misra M, Chitnis T. Adipokines are associated with pediatric multiple sclerosis risk and course. Multiple Sclerosis and Related Disorders. 36: 101384. PMID 31550559 DOI: 10.1016/J.Msard.2019.101384 |
0.426 |
|
| 2019 |
Deiva K, Huppke P, Banwell B, Chitnis T, Gärtner J, Krupp L, Waubant E, Stites T, Pearce GL, Merschhemke M. Consistent control of disease activity with fingolimod versus IFN β-1a in paediatric-onset multiple sclerosis: further insights from PARADIG. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 31467033 DOI: 10.1136/Jnnp-2019-321124 |
0.422 |
|
| 2019 |
Palotai M, Cavallari M, Koubiyr I, Morales Pinzon A, Nazeri A, Healy BC, Glanz B, Weiner HL, Chitnis T, Guttmann CR. Microstructural fronto-striatal and temporo-insular alterations are associated with fatigue in patients with multiple sclerosis independent of white matter lesion load and depression. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519869185. PMID 31418637 DOI: 10.1177/1352458519869185 |
0.437 |
|
| 2019 |
Papantoniou K, Massa J, Devore E, Munger KL, Chitnis T, Ascherio A, Schernhammer ES. Rotating night shift work and risk of multiple sclerosis in the Nurses' Health Studies. Occupational and Environmental Medicine. PMID 31405910 DOI: 10.1136/Oemed-2019-106016 |
0.387 |
|
| 2019 |
Yano H, Gonzalez C, Healy BC, Glanz BI, Weiner HL, Chitnis T. Discontinuation of disease-modifying therapy for patients with relapsing-remitting multiple sclerosis: Effect on clinical and MRI outcomes. Multiple Sclerosis and Related Disorders. 35: 119-127. PMID 31374460 DOI: 10.1016/J.Msard.2019.07.021 |
0.461 |
|
| 2019 |
Bove R, Rankin K, Lin C, Zhao C, Correale J, Hellwig K, Michel L, Laplaud DA, Chitnis T. Effect of assisted reproductive technology on multiple sclerosis relapses: Case series and meta-analysis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519865118. PMID 31368394 DOI: 10.1177/1352458519865118 |
0.424 |
|
| 2019 |
Tyshkov C, Pawate S, Bradshaw MJ, Kimbrough DJ, Chitnis T, Gelfand JM, Ryerson LZ, Kister I. Multiple sclerosis and sarcoidosis: A case for coexistence. Neurology. Clinical Practice. 9: 218-227. PMID 31341709 DOI: 10.1212/CPJ.0000000000000629 |
0.375 |
|
| 2019 |
Santoro JD, Chitnis T. Diagnostic Considerations in Acute Disseminated Encephalomyelitis and the Interface with MOG Antibody. Neuropediatrics. PMID 31340401 DOI: 10.1055/S-0039-1693152 |
0.319 |
|
| 2019 |
Ghezzi A, Chitnis T, K-Laflamme A, Meinert R, Häring DA, Pohl D. Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing-Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMS II Trials. Neurology and Therapy. PMID 31325110 DOI: 10.1007/S40120-019-0146-Z |
0.455 |
|
| 2019 |
Rhead B, Shao X, Graves JS, Chitnis T, Waldman AT, Lotze T, Schreiner T, Belman A, Krupp L, Greenberg BM, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Hart J, et al. miRNA contributions to pediatric-onset multiple sclerosis inferred from GWAS. Annals of Clinical and Translational Neurology. 6: 1053-1061. PMID 31211169 DOI: 10.1002/Acn3.786 |
0.469 |
|
| 2019 |
Zurawski J, Glanz BI, Healy BC, Tauhid S, Khalid F, Chitnis T, Weiner HL, Bakshi R. The impact of cervical spinal cord atrophy on quality of life in multiple sclerosis. Journal of the Neurological Sciences. 403: 38-43. PMID 31207364 DOI: 10.1016/J.Jns.2019.04.023 |
0.351 |
|
| 2019 |
Graves JS, Barcellos LF, Krupp L, Belman A, Shao X, Quach H, Hart J, Chitnis T, Weinstock-Guttman B, Aaen G, Benson L, Gorman M, Greenberg B, Lotze T, Soe M, et al. Vitamin D genes influence MS relapses in children. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519845842. PMID 31081484 DOI: 10.1177/1352458519845842 |
0.379 |
|
| 2019 |
Waubant E, Banwell B, Wassmer E, Sormani MP, Amato MP, Hintzen R, Krupp L, Rostásy K, Tenembaum S, Chitnis T. Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG. Neurology. PMID 31043474 DOI: 10.1212/Wnl.0000000000007572 |
0.382 |
|
| 2019 |
Cortese M, Chitnis T, Ascherio A, Munger KL. Total intake of different minerals and the risk of multiple sclerosis. Neurology. PMID 30944237 DOI: 10.1212/Wnl.0000000000006800 |
0.392 |
|
| 2019 |
Zurawski J, Glanz BI, Chua A, Lokhande H, Rotstein D, Weiner H, Engler D, Chitnis T, Healy BC. Time between expanded disability status scale (EDSS) scores. Multiple Sclerosis and Related Disorders. 30: 98-103. PMID 30763908 DOI: 10.1016/J.Msard.2019.02.007 |
0.319 |
|
| 2019 |
Hemond CC, Glanz BI, Bakshi R, Chitnis T, Healy BC. The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with neurological disability and brain atrophy in multiple sclerosis. Bmc Neurology. 19: 23. PMID 30755165 DOI: 10.1186/S12883-019-1245-2 |
0.36 |
|
| 2019 |
Chi C, Shao X, Rhead B, Gonzales E, Smith JB, Xiang AH, Graves J, Waldman A, Lotze T, Schreiner T, Weinstock-Guttman B, Aaen G, Tillema JM, Ness J, Candee M, ... ... Chitnis T, et al. Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry. Plos Genetics. 15: e1007808. PMID 30653506 DOI: 10.1371/Journal.Pgen.1007808 |
0.445 |
|
| 2019 |
Bradshaw MJ, Lisak RP, Meltzer E, Melamed E, Lucas A, Freeman L, Frohman TC, Costello K, Balcer L, Galetta S, Chitnis T, Zamvil SS, Frohman EM. A young man in "double-trouble": Hallucinations and cranial nerve palsies: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurology(R) Neuroimmunology & Neuroinflammation. 6: e526. PMID 30637300 DOI: 10.1212/Nxi.0000000000000526 |
0.357 |
|
| 2019 |
Desai RJ, Mahesri M, Gagne JJ, Hurley E, Tong A, Chitnis T, Minden S, Spettell CM, Matlin OS, Shrank WH, Choudhry NK. Utilization Patterns of Oral Disease-Modifying Drugs in Commercially Insured Patients with Multiple Sclerosis. Journal of Managed Care & Specialty Pharmacy. 25: 113-121. PMID 30589630 DOI: 10.18553/Jmcp.2019.25.1.113 |
0.466 |
|
| 2018 |
Chitnis T, Gonzalez C, Healy BC, Saxena S, Rosso M, Barro C, Michalak Z, Paul A, Kivisakk P, Diaz-Cruz C, Sattarnezhad N, Pierre IV, Glanz BI, Tomic D, Kropshofer H, et al. Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis. Annals of Clinical and Translational Neurology. 5: 1478-1491. PMID 30564615 DOI: 10.1002/Acn3.638 |
0.431 |
|
| 2018 |
Fakih R, Diaz-Cruz C, Chua AS, Gonzalez C, Healy BC, Sattarnezhad N, Glanz BI, Weiner HL, Chitnis T. Food allergies are associated with increased disease activity in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 30563943 DOI: 10.1136/Jnnp-2018-319301 |
0.509 |
|
| 2018 |
Aaen G, Waltz M, Vargas W, Makhani N, Ness J, Harris Y, Casper TC, Benson L, Candee M, Chitnis T, Gorman M, Graves J, Greenberg B, Lotze T, Mar S, et al. Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis. Journal of Child Neurology. 883073818815041. PMID 30556452 DOI: 10.1177/0883073818815041 |
0.399 |
|
| 2018 |
Chitnis T. Beyond the band: A biomarker for pediatric MS? Multiple Sclerosis (Houndmills, Basingstoke, England). 24: 1655-1656. PMID 30422760 DOI: 10.1177/1352458518803778 |
0.424 |
|
| 2018 |
Waubant E, Amezcua L, Sicotte N, Hellwig K, Krupp L, Weinstock-Guttman B, Yeh A, Lucas RM, Longbrake EE, Yadav V, Rensel M, Mar S, Hersh C, Block V, Zipp F, ... ... Chitnis T, et al. Gender Inequities in the Multiple Sclerosis Community: A Call for Action Annals of Neurology. 84: 958-959. PMID 30387521 DOI: 10.1002/Ana.25359 |
0.341 |
|
| 2018 |
Healy BC, Zurawski J, Gonzalez CT, Chitnis T, Weiner HL, Glanz BI. Assessment of computer adaptive testing version of the Neuro-QOL for people with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518810159. PMID 30381985 DOI: 10.1177/1352458518810159 |
0.401 |
|
| 2018 |
Rotstein DL, Cortese M, Fung TT, Chitnis T, Ascherio A, Munger KL. Diet quality and risk of multiple sclerosis in two cohorts of US women. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518807061. PMID 30351179 DOI: 10.1177/1352458518807061 |
0.403 |
|
| 2018 |
Nourbakhsh B, Rutatangwa A, Waltz M, Rensel M, Moodley M, Graves J, Casper TC, Waldman A, Belman A, Greenberg B, Goyal M, Harris Y, Kahn I, Lotze T, Mar S, ... ... Chitnis T, et al. Heterogeneity in association of remote herpesvirus infections and pediatric MS. Annals of Clinical and Translational Neurology. 5: 1222-1228. PMID 30349857 DOI: 10.1002/Acn3.636 |
0.409 |
|
| 2018 |
Lavery AM, Waubant E, Casper TC, Roalstad S, Candee M, Rose J, Belman A, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Ness J, Harris Y, Graves J, Krupp L, ... ... Chitnis T, et al. Urban air quality and associations with pediatric multiple sclerosis. Annals of Clinical and Translational Neurology. 5: 1146-1153. PMID 30349849 DOI: 10.1002/Acn3.616 |
0.382 |
|
| 2018 |
Zivadinov R, Medin J, Khan N, Korn JR, Chitnis T, Naismith RT, Alvarez E, Dwyer MG, Bergsland N, Carl E, Silva D, Weinstock-Guttman B. Impact of fingolimod on clinical and magnetic resonance imaging outcomes in routine clinical practice: A retrospective analysis of the multiple sclerosis, clinical and MRI outcomes in the USA (MS-MRIUS) study. Multiple Sclerosis and Related Disorders. 27: 65-73. PMID 30342416 DOI: 10.1016/J.Msard.2018.09.037 |
0.426 |
|
| 2018 |
Krysko KM, Graves J, Rensel M, Weinstock-Guttman B, Aaen G, Benson L, Chitnis T, Gorman M, Goyal M, Krupp L, Lotze T, Mar S, Rodriguez M, Rose J, Waltz M, et al. Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US. Neurology. PMID 30333163 DOI: 10.1212/Wnl.0000000000006471 |
0.481 |
|
| 2018 |
Dastagir A, Healy BC, Chua AS, Chitnis T, Weiner HL, Bakshi R, Tauhid S. Brain and spinal cord MRI lesions in primary progressive vs. relapsing-remitting multiple sclerosis. Eneurologicalsci. 12: 42-46. PMID 30229136 DOI: 10.1016/J.Ensci.2018.07.002 |
0.485 |
|
| 2018 |
Chitnis T, Arnold DL, Banwell B, Brück W, Ghezzi A, Giovannoni G, Greenberg B, Krupp L, Rostásy K, Tardieu M, Waubant E, Wolinsky JS, Bar-Or A, Stites T, Chen Y, et al. Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis. The New England Journal of Medicine. 379: 1017-1027. PMID 30207920 DOI: 10.1056/Nejmoa1800149 |
0.358 |
|
| 2018 |
Fakih R, Matiello M, Chitnis T, Stankiewicz JM. Efficacy and safety of mycophenolate mofetil in progressive multiple sclerosis patients. Journal of Neurology. PMID 30203314 DOI: 10.1007/S00415-018-9050-1 |
0.52 |
|
| 2018 |
Regev K, Healy BC, Paul A, Diaz-Cruz C, Mazzola MA, Raheja R, Glanz BI, Kivisäkk P, Chitnis T, Jagodic M, Piehl F, Olsson T, Khademi M, Hauser S, Oksenberg J, et al. Identification of MS-specific serum miRNAs in an international multicenter study. Neurology(R) Neuroimmunology & Neuroinflammation. 5: e491. PMID 30175165 DOI: 10.1212/Nxi.0000000000000491 |
0.414 |
|
| 2018 |
Khalid F, Healy BC, Dupuy SL, Chu R, Chitnis T, Bakshi R, Houtchens M. Quantitative MRI analysis of cerebral lesions and atrophy in post-partum patients with multiple sclerosis. Journal of the Neurological Sciences. 392: 94-99. PMID 30031994 DOI: 10.1016/J.Jns.2018.06.025 |
0.452 |
|
| 2018 |
Leclaire K, Cecil A, LaRussa A, Stuart F, Hemond CC, Healy BC, Chitnis T, Weiner H, Huffman J, Glanz BI. A Pilot Study of a Group Positive Psychology Intervention for Patients with Multiple Sclerosis. International Journal of Ms Care. 20: 136-141. PMID 29896050 DOI: 10.7224/1537-2073.2017-002 |
0.349 |
|
| 2018 |
Gärtner J, Chitnis T, Ghezzi A, Pohl D, Brück W, Häring DA, Karlsson G, Putzki N. Relapse Rate and MRI Activity in Young Adult Patients With Multiple Sclerosis: A Post Hoc Analysis of Phase 3 Fingolimod Trials. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 4: 2055217318778610. PMID 29854416 DOI: 10.1177/2055217318778610 |
0.416 |
|
| 2018 |
Zivadinov R, Medin J, Khan N, Korn JR, Bergsland N, Dwyer MG, Chitnis T, Naismith RT, Alvarez E, Kinkel P, Cohan S, Hunter SF, Silva D, Weinstock-Guttman B. Fingolimod's Impact on MRI Brain Volume Measures in Multiple Sclerosis: Results from MS-MRIUS. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 29749661 DOI: 10.1111/Jon.12518 |
0.503 |
|
| 2018 |
Chitnis T, Giovannoni G, Trojano M. Complexity of MS management in the current treatment era. Neurology. 90: 761-762. PMID 29686111 DOI: 10.1212/Wnl.0000000000005399 |
0.481 |
|
| 2018 |
Suleiman L, Waubant E, Aaen G, Belman A, Benson L, Candee M, Chitnis T, Gorman M, Goyal M, Greenberg B, Harris Y, Hart J, Kahn I, Krupp L, Lotze T, et al. Early infectious exposures are not associated with increased risk of pediatric-onset multiple sclerosis. Multiple Sclerosis and Related Disorders. 22: 103-107. PMID 29653437 DOI: 10.1016/J.Msard.2018.03.015 |
0.395 |
|
| 2018 |
Raheja R, Regev K, Healy BC, Mazzola MA, Beynon V, von Glehn F, Paul A, Diaz-Cruz C, Gholipour T, Glanz BI, Kivisakk P, Chitnis T, Weiner HL, Berry JD, Gandhi R. Correlating serum microRNAs and clinical parameters in Amyotrophic lateral sclerosis. Muscle & Nerve. PMID 29466830 DOI: 10.1002/Mus.26106 |
0.697 |
|
| 2018 |
Bove R, Healy BC, Musallam A, Soltany P, Diaz-Cruz C, Sattarnezhad N, Glanz BI, Kivisäkk P, Miller KK, Chitnis T. Fatty acid binding protein-4 is associated with disability in multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517750768. PMID 29320952 DOI: 10.1177/1352458517750768 |
0.513 |
|
| 2018 |
Chitnis T. The role of testosterone in MS risk and course. Multiple Sclerosis (Houndmills, Basingstoke, England). 24: 36-41. PMID 29307293 DOI: 10.1177/1352458517737395 |
0.514 |
|
| 2017 |
Baharnoori M, Gonzalez CT, Chua A, Diaz-Cruz C, Healy BC, Stankiewicz J, Weiner HL, Chitnis T. Predictors of hematological abnormalities in multiple sclerosis patients treated with fingolimod and dimethyl fumarate and impact of treatment switch on lymphocyte and leukocyte count. Multiple Sclerosis and Related Disorders. 20: 51-57. PMID 29304497 DOI: 10.1016/J.Msard.2017.12.003 |
0.466 |
|
| 2017 |
Cavallari M, Egorova S, Healy BC, Palotai M, Prieto JC, Polgar-Turcsanyi M, Tauhid S, Anderson M, Glanz B, Chitnis T, Guttmann CRG. Evaluating the Association between Enlarged Perivascular Spaces and Disease Worsening in Multiple Sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 29226505 DOI: 10.1111/Jon.12490 |
0.529 |
|
| 2017 |
Bradshaw MJ, Farrow S, Motl RW, Chitnis T. Wearable biosensors to monitor disability in multiple sclerosis. Neurology. Clinical Practice. 7: 354-362. PMID 29185551 DOI: 10.1212/CPJ.0000000000000382 |
0.38 |
|
| 2017 |
Yousuf F, Dupuy SL, Tauhid S, Chu R, Kim G, Tummala S, Khalid F, Weiner HL, Chitnis T, Healy BC, Bakshi R. A two-year study using cerebral gray matter volume to assess the response to fingolimod therapy in multiple sclerosis. Journal of the Neurological Sciences. PMID 29146095 DOI: 10.1016/J.Jns.2017.10.019 |
0.508 |
|
| 2017 |
Eagle T, Stuart F, Chua AS, LaRussa A, Leclaire K, Cook SL, Chitnis T, Weiner HL, Glanz BI, Healy BC. Treatment satisfaction across injectable, infusion, and oral disease-modifying therapies for multiple sclerosis. Multiple Sclerosis and Related Disorders. 18: 196-201. PMID 29141809 DOI: 10.1016/J.Msard.2017.10.002 |
0.456 |
|
| 2017 |
Lavery AM, Waldman AT, Charles Casper T, Roalstad S, Candee M, Rose J, Belman A, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Ness J, Harris Y, Graves J, Krupp L, ... ... Chitnis T, et al. Examining the contributions of environmental quality to pediatric multiple sclerosis. Multiple Sclerosis and Related Disorders. 18: 164-169. PMID 29141802 DOI: 10.1016/J.Msard.2017.09.004 |
0.419 |
|
| 2017 |
Diaz-Cruz C, Chua AS, Malik MT, Kaplan T, Glanz BI, Egorova S, Guttmann CRG, Bakshi R, Weiner HL, Healy BC, Chitnis T. The effect of alcohol and red wine consumption on clinical and MRI outcomes in multiple sclerosis. Multiple Sclerosis and Related Disorders. 17: 47-53. PMID 29055473 DOI: 10.1016/J.Msard.2017.06.011 |
0.428 |
|
| 2017 |
Azary S, Schreiner T, Graves J, Waldman A, Belman A, Guttman BW, Aaen G, Tillema JM, Mar S, Hart J, Ness J, Harris Y, Krupp L, Gorman M, Benson L, ... ... Chitnis T, et al. Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28993476 DOI: 10.1136/Jnnp-2017-315936 |
0.493 |
|
| 2017 |
Gianfrancesco MA, Stridh P, Shao X, Rhead B, Graves JS, Chitnis T, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, et al. Genetic risk factors for pediatric-onset multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517733551. PMID 28980494 DOI: 10.1177/1352458517733551 |
0.366 |
|
| 2017 |
Palacios N, Munger KL, Fitzgerald KC, Hart JE, Chitnis T, Ascherio A, Laden F. Exposure to particulate matter air pollution and risk of multiple sclerosis in two large cohorts of US nurses. Environment International. 109: 64-72. PMID 28938101 DOI: 10.1016/J.Envint.2017.07.013 |
0.351 |
|
| 2017 |
Chitnis T, Weiner HL. CNS inflammation and neurodegeneration. The Journal of Clinical Investigation. PMID 28872464 DOI: 10.1172/Jci90609 |
0.401 |
|
| 2017 |
Greeke EE, Chua AS, Healy BC, Rintell DJ, Chitnis T, Glanz BI. Depression and fatigue in patients with multiple sclerosis. Journal of the Neurological Sciences. 380: 236-241. PMID 28870578 DOI: 10.1016/J.Jns.2017.07.047 |
0.41 |
|
| 2017 |
Bove R, Chitnis T, Cree BA, Tintoré M, Naegelin Y, Uitdehaag BM, Kappos L, Khoury SJ, Montalban X, Hauser SL, Weiner HL. SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517726657. PMID 28847219 DOI: 10.1177/1352458517726657 |
0.507 |
|
| 2017 |
Cortese M, Yuan C, Chitnis T, Ascherio A, Munger KL. No association between dietary sodium intake and the risk of multiple sclerosis. Neurology. PMID 28842447 DOI: 10.1212/Wnl.0000000000004417 |
0.425 |
|
| 2017 |
Pakpoor J, Seminatore B, Graves JS, Schreiner T, Waldman AT, Lotze TE, Belman A, Greenberg BM, Weinstock-Guttman B, Aaen G, Tillema JM, McDonald JC, Hart J, Ness JM, Harris Y, ... ... Chitnis T, et al. Dietary factors and pediatric multiple sclerosis: A case-control study. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517713343. PMID 28608728 DOI: 10.1177/1352458517713343 |
0.502 |
|
| 2017 |
Sattarnezhad N, Farrow S, Kimbrough D, Glanz B, Healy B, Chitnis T. Agreement analysis comparing iPad LCVA and Sloan testing in multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517713667. PMID 28585909 DOI: 10.1177/1352458517713667 |
0.329 |
|
| 2017 |
Graves JS, Chitnis T, Weinstock-Guttman B, Rubin J, Zelikovitch AS, Nourbakhsh B, Simmons T, Waltz M, Casper TC, Waubant E. Maternal and Perinatal Exposures Are Associated With Risk for Pediatric-Onset Multiple Sclerosis. Pediatrics. 139. PMID 28562303 DOI: 10.1542/Peds.2016-2838 |
0.421 |
|
| 2017 |
Zhao Y, Healy BC, Rotstein D, Guttmann CR, Bakshi R, Weiner HL, Brodley CE, Chitnis T. Exploration of machine learning techniques in predicting multiple sclerosis disease course. Plos One. 12: e0174866. PMID 28379999 DOI: 10.1371/Journal.Pone.0174866 |
0.318 |
|
| 2017 |
Gianfrancesco MA, Stridh P, Rhead B, Shao X, Xu E, Graves JS, Chitnis T, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, et al. Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS. Neurology. PMID 28356466 DOI: 10.1212/Wnl.0000000000003849 |
0.412 |
|
| 2017 |
Bourne T, Waltz M, Casper TC, Kavak K, Aaen G, Belman A, Benson L, Candee M, Chitnis T, Graves J, Greenberg B, Gorman M, Harris Y, Krupp L, Lotze T, et al. Evaluating the association of allergies with multiple sclerosis susceptibility risk and disease activity in a pediatric population. Journal of the Neurological Sciences. 375: 371-375. PMID 28320170 DOI: 10.1016/J.Jns.2017.02.041 |
0.502 |
|
| 2017 |
Healy BC, Buckle GJ, Ali EN, Egorova S, Khalid F, Tauhid S, Glanz BI, Chitnis T, Guttmann CR, Weiner HL, Bakshi R. Characterizing Clinical and MRI Dissociation in Patients with Multiple Sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 28261936 DOI: 10.1111/Jon.12433 |
0.457 |
|
| 2017 |
Bjørnevik K, Chitnis T, Ascherio A, Munger KL. Polyunsaturated fatty acids and the risk of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517691150. PMID 28156186 DOI: 10.1177/1352458517691150 |
0.398 |
|
| 2017 |
Bove R, Rankin K, Chua AS, Saraceno T, Sattarnezhad N, Greeke E, Stuart F, LaRussa A, Glanz BI, Chitnis T. Oral contraceptives and MS disease activity in a contemporary real-world cohort. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517692420. PMID 28155573 DOI: 10.1177/1352458517692420 |
0.506 |
|
| 2017 |
Regev K, Healy BC, Khalid F, Paul A, Chu R, Tauhid S, Tummala S, Diaz-Cruz C, Raheja R, Mazzola MA, von Glehn F, Kivisakk P, Dupuy SL, Kim G, Chitnis T, et al. Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity. Jama Neurology. PMID 28114622 DOI: 10.1001/Jamaneurol.2016.5197 |
0.375 |
|
| 2017 |
Kim G, Chu R, Yousuf F, Tauhid S, Stazzone L, Houtchens MK, Stankiewicz JM, Severson C, Kimbrough D, Quintana F, Chitnis T, Weiner HL, Healy BC, Bakshi R. Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis. The International Journal of Neuroscience. 1-34. PMID 28100092 DOI: 10.1080/00207454.2017.1283313 |
0.414 |
|
| 2017 |
Kim GY, Saxena S, Chitnis T. Clinical Course and Treatment in MOG Antibody Seropositive Children: A Case Series Journal of Pediatric Neurology. 17: 31-37. DOI: 10.1055/S-0037-1608795 |
0.459 |
|
| 2016 |
Chitnis T, Graves J, Weinstock-Guttman B, Belman A, Olsen C, Misra M, Aaen G, Benson L, Candee M, Gorman M, Greenberg B, Krupp L, Lotze T, Mar S, Ness J, et al. Distinct effects of obesity and puberty on risk and age at onset of pediatric MS. Annals of Clinical and Translational Neurology. 3: 897-907. PMID 28097202 DOI: 10.1002/Acn3.365 |
0.397 |
|
| 2016 |
Koelman DL, Benkeser DC, Xu Y, Neo SX, Tan K, Katsuno M, Sobue G, Natsume J, Chahin S, Mar SS, Venkatesan A, Chitnis T, Hoganson GM, Yeshokumar AK, Barreras P, et al. Acute disseminated encephalomyelitis in China, Singapore and Japan: a comparison with the USA. European Journal of Neurology. PMID 28009079 DOI: 10.1111/Ene.13220 |
0.371 |
|
| 2016 |
Dorans KS, Massa J, Chitnis T, Ascherio A, Munger KL. Physical activity and the incidence of multiple sclerosis. Neurology. PMID 27683852 DOI: 10.1212/Wnl.0000000000003260 |
0.447 |
|
| 2016 |
Bove R, Vaughan T, Chitnis T, Wicks P, De Jager PL. Women's experiences of menopause in an online MS cohort: A case series. Multiple Sclerosis and Related Disorders. 9: 56-9. PMID 27645345 DOI: 10.1016/J.Msard.2016.06.015 |
0.492 |
|
| 2016 |
Regev K, Paul A, Healy B, von Glenn F, Diaz-Cruz C, Gholipour T, Mazzola MA, Raheja R, Nejad P, Glanz BI, Kivisakk P, Chitnis T, Weiner HL, Gandhi R. Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis. Neurology® Neuroimmunology & Neuroinflammation. 3: e267. PMID 27606352 DOI: 10.1212/Nxi.0000000000000267 |
0.727 |
|
| 2016 |
Bove R, White CC, Fitzgerald KC, Chitnis T, Chibnik L, Ascherio A, Munger KL. Hormone therapy use and physical quality of life in postmenopausal women with multiple sclerosis. Neurology. PMID 27605175 DOI: 10.1212/Wnl.0000000000003176 |
0.352 |
|
| 2016 |
Tenembaum S, Chitnis T, Nakashima I, Collongues N, McKeon A, Levy M, Rostasy K. Neuromyelitis optica spectrum disorders in children and adolescents. Neurology. 87: S59-66. PMID 27572863 DOI: 10.1212/Wnl.0000000000002824 |
0.314 |
|
| 2016 |
Bar-Or A, Hintzen RQ, Dale RC, Rostasy K, Brück W, Chitnis T. Immunopathophysiology of pediatric CNS inflammatory demyelinating diseases. Neurology. 87: S12-9. PMID 27572856 DOI: 10.1212/Wnl.0000000000002821 |
0.518 |
|
| 2016 |
Wassmer E, Chitnis T, Pohl D, Amato MP, Banwell B, Ghezzi A, Hintzen RQ, Krupp LB, Makhani N, Rostásy K, Tardieu M, Tenembaum S, Waldman A, Waubant E, Kornberg AJ. International Pediatric MS Study Group Global Members Symposium report. Neurology. 87: S110-6. PMID 27572855 DOI: 10.1212/Wnl.0000000000002880 |
0.516 |
|
| 2016 |
Chitnis T, Ghezzi A, Bajer-Kornek B, Boyko A, Giovannoni G, Pohl D. Pediatric multiple sclerosis: Escalation and emerging treatments. Neurology. 87: S103-9. PMID 27572854 DOI: 10.1212/Wnl.0000000000002884 |
0.439 |
|
| 2016 |
Bove R, Chua AS, Xia Z, Chibnik L, De Jager PL, Chitnis T. Complex relation of HLA-DRB1*1501, age at menarche, and age at multiple sclerosis onset. Neurology. Genetics. 2: e88. PMID 27504495 DOI: 10.1212/Nxg.0000000000000088 |
0.434 |
|
| 2016 |
Bove R, Musallam A, Xia Z, Baruch N, Messina S, Healy BC, Chitnis T. Longitudinal BMI trajectories in multiple sclerosis: Sex differences in association with disease severity. Multiple Sclerosis and Related Disorders. 8: 136-40. PMID 27456889 DOI: 10.1016/J.Msard.2016.05.019 |
0.462 |
|
| 2016 |
Belman AL, Krupp LB, Olsen CS, Rose JW, Aaen G, Benson L, Chitnis T, Gorman M, Graves J, Harris Y, Lotze T, Ness J, Rodriguez M, Tillema JM, Waubant E, et al. Characteristics of Children and Adolescents With Multiple Sclerosis. Pediatrics. PMID 27358474 DOI: 10.1542/Peds.2016-0120 |
0.481 |
|
| 2016 |
Jangi S, Gandhi R, Cox LM, Li N, von Glehn F, Yan R, Patel B, Mazzola MA, Liu S, Glanz BL, Cook S, Tankou S, Stuart F, Melo K, Nejad P, ... ... Chitnis T, et al. Alterations of the human gut microbiome in multiple sclerosis. Nature Communications. 7: 12015. PMID 27352007 DOI: 10.1038/Ncomms12015 |
0.508 |
|
| 2016 |
Nourbakhsh B, Graves J, Casper TC, Lulu S, Waldman A, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Ness J, Rubin J, Krupp L, Gorman M, ... ... Chitnis T, et al. Dietary salt intake and time to relapse in paediatric multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27343226 DOI: 10.1136/Jnnp-2016-313410 |
0.508 |
|
| 2016 |
Simone M, Chitnis T. Use of Disease-Modifying Therapies in Pediatric MS. Current Treatment Options in Neurology. 18: 36. PMID 27314428 DOI: 10.1007/S11940-016-0420-7 |
0.413 |
|
| 2016 |
Koelman DL, Chahin S, Mar SS, Venkatesan A, Hoganson GM, Yeshokumar AK, Barreras P, Majmudar B, Klein JP, Chitnis T, Benkeser DC, Carone M, Mateen FJ. Acute disseminated encephalomyelitis in 228 patients: A retrospective, multicenter US study. Neurology. PMID 27164698 DOI: 10.1212/Wnl.0000000000002723 |
0.311 |
|
| 2016 |
Lee JY, Chitnis T. Pediatric Multiple Sclerosis. Seminars in Neurology. 36: 148-153. PMID 27116721 DOI: 10.1055/S-0036-1579738 |
0.543 |
|
| 2016 |
McDonald J, Graves J, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Lulu S, Ness J, Harris Y, Rubin J, ... ... Chitnis T, et al. A case-control study of dietary salt intake in pediatric-onset multiple sclerosis. Multiple Sclerosis and Related Disorders. 6: 87-92. PMID 27063630 DOI: 10.1016/J.Msard.2016.02.011 |
0.422 |
|
| 2016 |
Cavallari M, Palotai M, Glanz BI, Egorova S, Prieto JC, Healy BC, Chitnis T, Guttmann CR. Fatigue predicts disease worsening in relapsing-remitting multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26920374 DOI: 10.1177/1352458516635874 |
0.381 |
|
| 2016 |
Chitnis T, Pohl D. Pediatric demyelinating disorders Neurology. 87: S1-S3. DOI: 10.1212/Wnl.0000000000002882 |
0.426 |
|
| 2015 |
Mazzola MA, Raheja R, Murugaiyan G, Rajabi H, Kumar D, Pertel T, Regev K, Griffin R, Aly L, Kivisakk P, Nejad P, Patel B, Gwanyalla N, Hei H, Glanz B, ... Chitnis T, et al. Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation. Journal of Neuroinflammation. 12: 245. PMID 26714756 DOI: 10.1186/S12974-015-0460-Z |
0.345 |
|
| 2015 |
Chitnis T, Ness J, Krupp L, Waubant E, Hunt T, Olsen CS, Rodriguez M, Lotze T, Gorman M, Benson L, Belman A, Weinstock-Guttman B, Aaen G, Graves J, Patterson M, et al. Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report. Neurology. PMID 26683648 DOI: 10.1212/Wnl.0000000000002283 |
0.416 |
|
| 2015 |
Chua AS, Glanz BI, Guarino AJ, Cook SL, Greeke EE, Little GE, Chitnis T, Healy BC. Patient-reported outcomes in multiple sclerosis: Relationships among existing scales and the development of a brief measure. Multiple Sclerosis and Related Disorders. 4: 598-606. PMID 26590669 DOI: 10.1016/J.Msard.2015.09.004 |
0.418 |
|
| 2015 |
Xia Z, White CC, Owen EK, Von Korff A, Clarkson SR, McCabe CA, Cimpean M, Winn PA, Hoesing A, Steele SU, Cortese IC, Chitnis T, Weiner HL, Reich DS, Chibnik LB, et al. GEMS Project: A Platform to Investigate Multiple Sclerosis Risk. Annals of Neurology. PMID 26583565 DOI: 10.1002/Ana.24560 |
0.423 |
|
| 2015 |
Rotstein DL, Healy BC, Malik MT, Carruthers RL, Musallam AJ, Kivisakk P, Weiner HL, Glanz B, Chitnis T. Effect of vitamin D on MS activity by disease-modifying therapy class. Neurology® Neuroimmunology & Neuroinflammation. 2: e167. PMID 26568968 DOI: 10.1212/Nxi.0000000000000167 |
0.405 |
|
| 2015 |
Bove R, Healy BC, Musallam A, Glanz BI, De Jager PL, Chitnis T. Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26447063 DOI: 10.1177/1352458515606211 |
0.532 |
|
| 2015 |
Oommen VV, Tauhid S, Healy BC, Chua AS, Malik MT, Diaz-Cruz C, Dupuy SL, Weiner HL, Chitnis T, Bakshi R. The Effect of Fingolimod on Conversion of Acute Gadolinium-Enhancing Lesions to Chronic T1 Hypointensities in Multiple Sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 26445919 DOI: 10.1111/Jon.12307 |
0.433 |
|
| 2015 |
Bove R, Malik MT, Diaz-Cruz C, Chua A, Saraceno TJ, Bargiela D, Greeke E, Glanz BI, Healy BC, Chitnis T. The 2D:4D ratio, a proxy for prenatal androgen levels, differs in men with and without MS. Neurology. 85: 1209-13. PMID 26341868 DOI: 10.1212/Wnl.0000000000001990 |
0.376 |
|
| 2015 |
Liu J, Brodley CE, Healy BC, Chitnis T. Removing confounding factors via constraint-based clustering: An application to finding homogeneous groups of multiple sclerosis patients. Artificial Intelligence in Medicine. PMID 26253753 DOI: 10.1016/J.Artmed.2015.06.004 |
0.38 |
|
| 2015 |
Tauhid S, Chu R, Sasane R, Glanz BI, Neema M, Miller JR, Kim G, Signorovitch JE, Healy BC, Chitnis T, Weiner HL, Bakshi R. Brain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosis. Journal of Neurology. PMID 26205635 DOI: 10.1007/S00415-015-7853-X |
0.402 |
|
| 2015 |
Chua AS, Egorova S, Anderson MC, Polgar-Turcsanyi M, Chitnis T, Weiner HL, Guttmann CR, Bakshi R, Healy BC. Handling changes in MRI acquisition parameters in modeling whole brain lesion volume and atrophy data in multiple sclerosis subjects: Comparison of linear mixed-effect models. Neuroimage. Clinical. 8: 606-10. PMID 26199872 DOI: 10.1016/J.Nicl.2015.06.009 |
0.375 |
|
| 2015 |
Chua AS, Egorova S, Anderson MC, Polgar-Turcsanyi M, Chitnis T, Weiner HL, Guttmann CR, Bakshi R, Healy BC. Using multiple imputation to efficiently correct cerebral MRI whole brain lesion and atrophy data in patients with multiple sclerosis. Neuroimage. PMID 26093330 DOI: 10.1016/J.Neuroimage.2015.06.037 |
0.371 |
|
| 2015 |
Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 85: 177-89. PMID 26092914 DOI: 10.1212/Wnl.0000000000001729 |
0.39 |
|
| 2015 |
Baruch NF, O'Donnell EH, Glanz BI, Benedict RH, Musallam AJ, Healy BC, Rintell D, Chitnis T. Cognitive and patient-reported outcomes in adults with pediatric-onset multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26041802 DOI: 10.1177/1352458515588781 |
0.366 |
|
| 2015 |
Fernandez-Carbonell C, Vargas-Lowy D, Musallam A, Healy B, McLaughlin K, Wucherpfennig KW, Chitnis T. Clinical and MRI phenotype of children with MOG antibodies. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26041801 DOI: 10.1177/1352458515587751 |
0.3 |
|
| 2015 |
Pandit L, Asgari N, Apiwattanakul M, Palace J, Paul F, Leite MI, Kleiter I, Chitnis T. Demographic and clinical features of neuromyelitis optica: A review. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 845-53. PMID 25921037 DOI: 10.1177/1352458515572406 |
0.333 |
|
| 2015 |
Bove R, Healy BC, Secor E, Vaughan T, Katic B, Chitnis T, Wicks P, De Jager PL. Patients report worse MS symptoms after menopause: findings from an online cohort. Multiple Sclerosis and Related Disorders. 4: 18-24. PMID 25787049 DOI: 10.1016/J.Msard.2014.11.009 |
0.481 |
|
| 2015 |
Engler D, Chitnis T, Healy B. Joint assessment of dependent discrete disease state processes. Statistical Methods in Medical Research. PMID 25698716 DOI: 10.1177/0962280215569899 |
0.417 |
|
| 2015 |
Rotstein DL, Healy BC, Malik MT, Chitnis T, Weiner HL. Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort. Jama Neurology. 72: 152-8. PMID 25531931 DOI: 10.1001/Jamaneurol.2014.3537 |
0.485 |
|
| 2015 |
Raghavan K, Healy BC, Carruthers RL, Chitnis T. Progression rates and sample size estimates for PPMS based on the CLIMB study population. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 180-8. PMID 25070676 DOI: 10.1177/1352458514541976 |
0.364 |
|
| 2015 |
Bajer-Kornek B, Ghezzi A, Karlsson G, Häering D, Gärtner J, Chitnis T, Pohl D, Putzki N. OP69 – 2651: Safety and effect of fingolimod on no evidence of disease activity (NEDA-4) in young adult patients with relapsing-remitting multiple sclerosis European Journal of Paediatric Neurology. 19: S22. DOI: 10.1016/S1090-3798(15)30070-2 |
0.31 |
|
| 2015 |
Sadovnick D, Bove R, Chitnis T. The role of hormones and gender in MS Journal of the Neurological Sciences. 357: e472. DOI: 10.1016/J.Jns.2015.09.199 |
0.461 |
|
| 2014 |
Benson LA, Healy BC, Gorman MP, Baruch NF, Gholipour T, Musallam A, Chitnis T. Elevated relapse rates in pediatric compared to adult MS persist for at least 6 years. Multiple Sclerosis and Related Disorders. 3: 186-93. PMID 25878006 DOI: 10.1016/J.Msard.2013.06.004 |
0.739 |
|
| 2014 |
Chitnis T, Gorman MP. Impact of MS during the critical window of brain development. Neurology. 83: 2106-7. PMID 25378681 DOI: 10.1212/Wnl.0000000000001056 |
0.426 |
|
| 2014 |
Casper TC, Rose JW, Roalstad S, Waubant E, Aaen G, Belman A, Chitnis T, Gorman M, Krupp L, Lotze TE, Ness J, Patterson M, Rodriguez M, Weinstock-Guttman B, Browning B, et al. The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps. Journal of Child Neurology. PMID 25270659 DOI: 10.1177/0883073814550656 |
0.368 |
|
| 2014 |
Bakshi R, Neema M, Tauhid S, Healy BC, Glanz BI, Kim G, Miller J, Berkowitz JL, Bove R, Houtchens MK, Severson C, Stankiewicz JM, Stazzone L, Chitnis T, Guttmann CR, et al. An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2. Neuroreport. 25: 1156-61. PMID 25100554 DOI: 10.1097/Wnr.0000000000000244 |
0.379 |
|
| 2014 |
Glanz BI, Musallam A, Rintell DJ, Chitnis T, Weiner HL, Healy BC. Treatment satisfaction in multiple sclerosis. International Journal of Ms Care. 16: 68-75. PMID 25061430 DOI: 10.7224/1537-2073.2013-021 |
0.384 |
|
| 2014 |
Chitnis T, Waubant E. B-cell depletion in children with neuroimmunologic conditions: the learning curve. Neurology. 83: 111-2. PMID 24920852 DOI: 10.1212/Wnl.0000000000000576 |
0.317 |
|
| 2014 |
Carruthers RL, Rotstein DL, Healy BC, Chitnis T, Weiner HL, Buckle GJ. An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1381-90. PMID 24852928 DOI: 10.1177/1352458514535282 |
0.429 |
|
| 2014 |
Malik MT, Healy BC, Benson LA, Kivisakk P, Musallam A, Weiner HL, Chitnis T. Factors associated with recovery from acute optic neuritis in patients with multiple sclerosis. Neurology. 82: 2173-9. PMID 24850491 DOI: 10.1212/Wnl.0000000000000524 |
0.375 |
|
| 2014 |
Bove R, Musallam A, Healy BC, Raghavan K, Glanz BI, Bakshi R, Weiner H, De Jager PL, Miller KK, Chitnis T. Low testosterone is associated with disability in men with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1584-92. PMID 24710799 DOI: 10.1177/1352458514527864 |
0.533 |
|
| 2014 |
Charvet LE, O'Donnell EH, Belman AL, Chitnis T, Ness JM, Parrish J, Patterson M, Rodriguez M, Waubant E, Weinstock-Guttman B, Krupp LB. Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1502-10. PMID 24687807 DOI: 10.1177/1352458514527862 |
0.403 |
|
| 2014 |
Bove R, Chitnis T. The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 520-6. PMID 24561324 DOI: 10.1177/1352458513519181 |
0.494 |
|
| 2014 |
Linnoila J, Chitnis T. Balo concentric sclerosis in children: a case series. Journal of Child Neurology. 29: 603-7. PMID 24423690 DOI: 10.1177/0883073813517294 |
0.438 |
|
| 2014 |
Bove R, Chitnis T, Houtchens M. Menopause in multiple sclerosis: therapeutic considerations. Journal of Neurology. 261: 1257-68. PMID 24101131 DOI: 10.1007/S00415-013-7131-8 |
0.483 |
|
| 2014 |
Fernández Carbonell C, Benson L, Rintell D, Prince J, Chitnis T. Functional relapses in pediatric multiple sclerosis. Journal of Child Neurology. 29: 943-6. PMID 24065582 DOI: 10.1177/0883073813501873 |
0.467 |
|
| 2014 |
Kivisäkk P, Healy BC, Francois K, Gandhi R, Gholipour T, Egorova S, Sevdalinova V, Quintana F, Chitnis T, Weiner HL, Khoury SJ. Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 438-44. PMID 24005026 DOI: 10.1177/1352458513503052 |
0.745 |
|
| 2014 |
Gärtner J, Chitnis T, Banwell B, Karlsson G, Karan R, Merschhemke M, Putzki N, Li B, Griese B, Vormfelde S. PARADIGMS: Fingolimod in Children and Adolescents with MS Neuropediatrics. 45. DOI: 10.1055/S-0034-1390598 |
0.397 |
|
| 2014 |
Vormfelde S, Chitnis T, Karlsson G, Häring D, Ghezzi A, Pohl D, Putzki N, Fuchs A, Gärtner J. The Effect of Age on Efficacy of Fingolimod Treatment: Young Adult Patients with Multiple Sclerosis Demonstrate Higher Relative Reduction of Relapse Rates Neuropediatrics. 45. DOI: 10.1055/S-0034-1390558 |
0.38 |
|
| 2013 |
Xia Z, Secor E, Chibnik LB, Bove RM, Cheng S, Chitnis T, Cagan A, Gainer VS, Chen PJ, Liao KP, Shaw SY, Ananthakrishnan AN, Szolovits P, Weiner HL, Karlson EW, et al. Modeling disease severity in multiple sclerosis using electronic health records. Plos One. 8: e78927. PMID 24244385 DOI: 10.1371/Journal.Pone.0078927 |
0.509 |
|
| 2013 |
Chitnis T, Guttmann CR, Zaitsev A, Musallam A, Weinstock-Guttman B, Yeh A, Rodriguez M, Ness J, Gorman MP, Healy BC, Kuntz N, Chabas D, Strober JB, Waubant E, Krupp L, et al. Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study. Bmc Neurology. 13: 173. PMID 24225378 DOI: 10.1186/1471-2377-13-173 |
0.422 |
|
| 2013 |
Messina S, Vargas-Lowy D, Musallam A, Healy BC, Kivisakk P, Gandhi R, Bove R, Gholipour T, Khoury S, Weiner HL, Chitnis T. Increased leptin and A-FABP levels in relapsing and progressive forms of MS. Bmc Neurology. 13: 172. PMID 24215402 DOI: 10.1186/1471-2377-13-172 |
0.734 |
|
| 2013 |
Ottoboni L, Frohlich IY, Lee M, Healy BC, Keenan BT, Xia Z, Chitnis T, Guttmann CR, Khoury SJ, Weiner HL, Hafler DA, De Jager PL. Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus. Neurology. 81: 1891-9. PMID 24174586 DOI: 10.1212/01.Wnl.0000436612.66328.8A |
0.454 |
|
| 2013 |
Chitnis T, Khoury SJ. Sex influences in autoimmune disease. Clinical Immunology (Orlando, Fla.). 149: 169. PMID 24012474 DOI: 10.1016/J.Clim.2013.08.002 |
0.311 |
|
| 2013 |
Chitnis T. Paediatric MS is the same disease as adult MS: no. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1255-6. PMID 23996596 DOI: 10.1177/1352458513488842 |
0.508 |
|
| 2013 |
Bove R, Musallam A, Healy BC, Houtchens M, Glanz BI, Khoury S, Guttmann CR, De Jager PL, Chitnis T. No sex-specific difference in disease trajectory in multiple sclerosis patients before and after age 50. Bmc Neurology. 13: 73. PMID 23822612 DOI: 10.1186/1471-2377-13-73 |
0.388 |
|
| 2013 |
Fernández Carbonell C, Chitnis T. Inflammatory demyelinating diseases in children: an update. Minerva Pediatrica. 65: 307-23. PMID 23685382 |
0.325 |
|
| 2013 |
Chitnis T. Role of puberty in multiple sclerosis risk and course. Clinical Immunology (Orlando, Fla.). 149: 192-200. PMID 23623473 DOI: 10.1016/J.Clim.2013.03.014 |
0.503 |
|
| 2013 |
Van Haren K, Tomooka BH, Kidd BA, Banwell B, Bar-Or A, Chitnis T, Tenembaum SN, Pohl D, Rostasy K, Dale RC, O'Connor KC, Hafler DA, Steinman L, Robinson WH. Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1726-33. PMID 23612879 DOI: 10.1177/1352458513485653 |
0.444 |
|
| 2013 |
Bove R, Chitnis T. Sexual disparities in the incidence and course of MS. Clinical Immunology (Orlando, Fla.). 149: 201-10. PMID 23608496 DOI: 10.1016/J.Clim.2013.03.005 |
0.481 |
|
| 2013 |
Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC, Ghezzi A, Hintzen R, Kornberg A, Pohl D, Rostasy K, Tenembaum S, Wassmer E. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1261-7. PMID 23572237 DOI: 10.1177/1352458513484547 |
0.453 |
|
| 2013 |
Healy BC, Engler D, Glanz B, Musallam A, Chitnis T. Assessment of definitions of sustained disease progression in relapsing-remitting multiple sclerosis. Multiple Sclerosis International. 2013: 189624. PMID 23555057 DOI: 10.1155/2013/189624 |
0.446 |
|
| 2013 |
Bove R, Secor E, Healy BC, Musallam A, Vaughan T, Glanz BI, Greeke E, Weiner HL, Chitnis T, Wicks P, De Jager PL. Evaluation of an online platform for multiple sclerosis research: patient description, validation of severity scale, and exploration of BMI effects on disease course. Plos One. 8: e59707. PMID 23527256 DOI: 10.1371/Journal.Pone.0059707 |
0.477 |
|
| 2013 |
Chitnis T, Tardieu M, Amato MP, Banwell B, Bar-Or A, Ghezzi A, Kornberg A, Krupp LB, Pohl D, Rostasy K, Tenembaum S, Waubant E, Wassmer E. International Pediatric MS Study Group Clinical Trials Summit: meeting report. Neurology. 80: 1161-8. PMID 23509048 DOI: 10.1212/Wnl.0B013E318288694E |
0.452 |
|
| 2013 |
Gandhi R, Healy B, Gholipour T, Egorova S, Musallam A, Hussain MS, Nejad P, Patel B, Hei H, Khoury S, Quintana F, Kivisakk P, Chitnis T, Weiner HL. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Annals of Neurology. 73: 729-40. PMID 23494648 DOI: 10.1002/Ana.23880 |
0.686 |
|
| 2013 |
Vargas-Lowy D, Kivisäkk P, Gandhi R, Raddassi K, Soltany P, Gorman MP, Khoury SJ, Chitnis T. Increased Th17 response to myelin peptides in pediatric MS. Clinical Immunology (Orlando, Fla.). 146: 176-84. PMID 23352968 DOI: 10.1016/J.Clim.2012.12.008 |
0.404 |
|
| 2013 |
Waubant E, Mowry EM, Krupp L, Chitnis T, Yeh EA, Kuntz N, Ness J, Belman A, Milazzo M, Gorman M, Weinstock-Guttman B, Rodriguez M, James JA. Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 891-5. PMID 23232601 DOI: 10.1177/1352458512469693 |
0.389 |
|
| 2013 |
Chitnis T. Disease-modifying therapy of pediatric multiple sclerosis. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 10: 89-96. PMID 23224690 DOI: 10.1007/S13311-012-0158-1 |
0.517 |
|
| 2013 |
Julian L, Serafin D, Charvet L, Ackerson J, Benedict R, Braaten E, Brown T, O'Donnell E, Parrish J, Preston T, Zaccariello M, Belman A, Chitnis T, Gorman M, Ness J, et al. Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network. Journal of Child Neurology. 28: 102-7. PMID 23155206 DOI: 10.1177/0883073812464816 |
0.378 |
|
| 2013 |
Vishwas MS, Healy BC, Pienaar R, Gorman MP, Grant PE, Chitnis T. Diffusion tensor analysis of pediatric multiple sclerosis and clinically isolated syndromes. Ajnr. American Journal of Neuroradiology. 34: 417-23. PMID 22859275 DOI: 10.3174/Ajnr.A3216 |
0.448 |
|
| 2013 |
Gholipour T, Healy B, Dimakopolous E, Buckle G, Weiner H, Chitnis T. Clinical inflammatory activity associated with response to second-line treatments in multiple sclerosis Journal of the Neurological Sciences. 333: e409. DOI: 10.1016/J.Jns.2013.07.1478 |
0.687 |
|
| 2012 |
Glanz BI, Dégano IR, Rintell DJ, Chitnis T, Weiner HL, Healy BC. Work productivity in relapsing multiple sclerosis: associations with disability, depression, fatigue, anxiety, cognition, and health-related quality of life. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 15: 1029-35. PMID 23244804 DOI: 10.1016/J.Jval.2012.07.010 |
0.367 |
|
| 2012 |
Vargas-Lowy D, Chitnis T. Pathogenesis of pediatric multiple sclerosis. Journal of Child Neurology. 27: 1394-407. PMID 22952316 DOI: 10.1177/0883073812456084 |
0.534 |
|
| 2012 |
Ceccarelli A, Jackson JS, Tauhid S, Arora A, Gorky J, Dell'Oglio E, Bakshi A, Chitnis T, Khoury SJ, Weiner HL, Guttmann CR, Bakshi R, Neema M. The impact of lesion in-painting and registration methods on voxel-based morphometry in detecting regional cerebral gray matter atrophy in multiple sclerosis. Ajnr. American Journal of Neuroradiology. 33: 1579-85. PMID 22460341 DOI: 10.3174/Ajnr.A3083 |
0.405 |
|
| 2012 |
Bove RM, Healy B, Augustine A, Musallam A, Gholipour T, Chitnis T. Effect of gender on late-onset multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 1472-9. PMID 22383227 DOI: 10.1177/1352458512438236 |
0.749 |
|
| 2012 |
Healy BC, Degano IR, Schreck A, Rintell D, Weiner H, Chitnis T, Glanz BI. The impact of a recent relapse on patient-reported outcomes in subjects with multiple sclerosis. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 21: 1677-84. PMID 22237991 DOI: 10.1007/S11136-011-0108-0 |
0.354 |
|
| 2012 |
Gorman MP, Tillema JM, Ciliax AM, Guttmann CR, Chitnis T. Daclizumab use in patients with pediatric multiple sclerosis. Archives of Neurology. 69: 78-81. PMID 22232346 DOI: 10.1001/Archneurol.2011.581 |
0.523 |
|
| 2012 |
Moodie J, Healy BC, Buckle GJ, Gauthier SA, Glanz BI, Arora A, Ceccarelli A, Tauhid S, Han XM, Venkataraman A, Chitnis T, Khoury SJ, Guttmann CR, Weiner HL, Neema M, et al. Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: a longitudinal study. Journal of the Neurological Sciences. 315: 49-54. PMID 22209496 DOI: 10.1016/J.Jns.2011.11.040 |
0.381 |
|
| 2012 |
Chitnis T, Tenembaum S, Banwell B, Krupp L, Pohl D, Rostasy K, Yeh EA, Bykova O, Wassmer E, Tardieu M, Kornberg A, Ghezzi A. Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 116-27. PMID 22146610 DOI: 10.1177/1352458511430704 |
0.509 |
|
| 2012 |
Glanz BI, Healy BC, Hviid LE, Chitnis T, Weiner HL. Cognitive deterioration in patients with early multiple sclerosis: a 5-year study. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 38-43. PMID 21746743 DOI: 10.1136/Jnnp.2010.237834 |
0.369 |
|
| 2012 |
Vargas-Lowy D, Kivisaak P, Ghandi R, Raddassi K, Gorman M, Khoury S, Chitnis T. Increased Th17 Central Memory Response to Myelin Peptides in Pediatric Multiple Sclerosis (S60.005) Neurology. 78: S60.005-S60.005. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S60.005 |
0.317 |
|
| 2012 |
Gholipour T, Egorova S, Sevdalinova V, Healy B, Bakshi R, Guttmann C, Khoury S, Weiner H, Chitnis T. MRI Characteristics of Malignant Multiple Sclerosis (S50.001) Neurology. 78: S50.001-S50.001. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S50.001 |
0.684 |
|
| 2012 |
Bove R, Healy B, Houtchens M, Glanz B, Khoury S, Guttmann C, De Jager P, Chitnis T. Menopause May Not Modulate Disease Course in Multiple Sclerosis (P06.183) Neurology. 78: P06.183-P06.183. DOI: 10.1212/WNL.78.1_MEETINGABSTRACTS.P06.183 |
0.301 |
|
| 2012 |
Graves J, Krupp L, Weinstock-Guttman B, Strober J, Belman A, Yeh EA, Ness J, Gorman M, Rodriguez M, Chitnis T, Waubant E. EBV, CMV, and HSV IgG Titers Are Not Predictive of Subsequent Relapse Risk in Pediatric Multiple Sclerosis (P02.096) Neurology. 78: P02.096-P02.096. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P02.096 |
0.44 |
|
| 2012 |
Messina S, Vargas-Lowy D, Gandhi R, Kivisakk P, Healy B, Patti F, Zappia M, Khoury S, Weiner H, Chitnis T. Adipokine Levels in Relapsing and Progressive Forms of Multiple Sclerosis (P02.077) Neurology. 78: P02.077-P02.077. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P02.077 |
0.301 |
|
| 2012 |
Bove R, Secor E, Vaughan T, Wicks P, Glanz B, Weiner H, Chitnis T, De Jager P. Comparison of Demographic and Disease Characteristics in Patients with Multiple Sclerosis at an MS Clinic and on an Online Research Forum (P01.145) Neurology. 78: P01.145-P01.145. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P01.145 |
0.428 |
|
| 2012 |
Chitnis T. Pediatric Multiple Sclerosis and Acute Disseminated Encephalomyelitis Multiple Sclerosis: Diagnosis and Therapy. 101-135. DOI: 10.1002/9781119963714.ch5 |
0.318 |
|
| 2011 |
Mirzaei F, Michels KB, Munger K, O'Reilly E, Chitnis T, Forman MR, Giovannucci E, Rosner B, Ascherio A. Gestational vitamin D and the risk of multiple sclerosis in offspring. Annals of Neurology. 70: 30-40. PMID 21786297 DOI: 10.1002/Ana.22456 |
0.37 |
|
| 2011 |
Gholipour T, Healy B, Baruch NF, Weiner HL, Chitnis T. Demographic and clinical characteristics of malignant multiple sclerosis. Neurology. 76: 1996-2001. PMID 21646626 DOI: 10.1212/Wnl.0B013E31821E559D |
0.743 |
|
| 2011 |
Waubant E, Mowry EM, Krupp L, Chitnis T, Yeh EA, Kuntz N, Ness J, Chabas D, Strober J, McDonald J, Belman A, Milazzo M, Gorman M, Weinstock-Guttman B, Rodriguez M, et al. Common viruses associated with lower pediatric multiple sclerosis risk. Neurology. 76: 1989-95. PMID 21646624 DOI: 10.1212/Wnl.0B013E31821E552A |
0.487 |
|
| 2011 |
Healy B, Chitnis T, Engler D. Improving power to detect disease progression in multiple sclerosis through alternative analysis strategies. Journal of Neurology. 258: 1812-9. PMID 21472497 DOI: 10.1007/S00415-011-6021-1 |
0.361 |
|
| 2011 |
Chitnis T, Krupp L, Yeh A, Rubin J, Kuntz N, Strober JB, Chabas D, Weinstock-Guttmann B, Ness J, Rodriguez M, Waubant E. Pediatric multiple sclerosis. Neurologic Clinics. 29: 481-505. PMID 21439455 DOI: 10.1016/J.Ncl.2011.01.004 |
0.482 |
|
| 2011 |
Liguori M, Meier DS, Hildenbrand P, Healy BC, Chitnis T, Baruch NF, Khoury SJ, Weiner HL, Bakshi R, Barkhof F, Guttmann CR. One year activity on subtraction MRI predicts subsequent 4 year activity and progression in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 1125-31. PMID 21429902 DOI: 10.1136/Jnnp.2011.242115 |
0.405 |
|
| 2011 |
Hviid LE, Healy BC, Rintell DJ, Chitnis T, Weiner HL, Glanz BI. Patient reported outcomes in benign multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 876-84. PMID 21372114 DOI: 10.1177/1352458511398370 |
0.526 |
|
| 2011 |
Healy BC, Engler D, Gholipour T, Weiner H, Bakshi R, Chitnis T. Accounting for disease modifying therapy in models of clinical progression in multiple sclerosis. Journal of the Neurological Sciences. 303: 109-13. PMID 21251671 DOI: 10.1016/J.Jns.2010.12.024 |
0.695 |
|
| 2011 |
Yeh EA, Waubant E, Krupp LB, Ness J, Chitnis T, Kuntz N, Ramanathan M, Belman A, Chabas D, Gorman MP, Rodriguez M, Rinker JR, Weinstock-Guttman B. Multiple sclerosis therapies in pediatric patients with refractory multiple sclerosis. Archives of Neurology. 68: 437-44. PMID 21149803 DOI: 10.1001/Archneurol.2010.325 |
0.482 |
|
| 2011 |
Munger KL, Chitnis T, Frazier AL, Giovannucci E, Spiegelman D, Ascherio A. Dietary intake of vitamin D during adolescence and risk of multiple sclerosis. Journal of Neurology. 258: 479-85. PMID 20945071 DOI: 10.1007/S00415-010-5783-1 |
0.355 |
|
| 2011 |
Chitnis T, Bar-Or A. Pediatric MS: Biological presentation and research update Demyelinating Disorders of the Central Nervous System in Childhood. 157-168. DOI: 10.1017/CBO9780511974373.016 |
0.344 |
|
| 2010 |
Xia Z, Chibnik LB, Glanz BI, Liguori M, Shulman JM, Tran D, Khoury SJ, Chitnis T, Holyoak T, Weiner HL, Guttmann CR, De Jager PL. A putative Alzheimer's disease risk allele in PCK1 influences brain atrophy in multiple sclerosis. Plos One. 5: e14169. PMID 21152065 DOI: 10.1371/Journal.Pone.0014169 |
0.429 |
|
| 2010 |
Healy BC, Glanz BI, Stankiewicz J, Buckle G, Weiner H, Chitnis T. A method for evaluating treatment switching criteria in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 1483-9. PMID 20736245 DOI: 10.1177/1352458510379245 |
0.406 |
|
| 2010 |
Healy BC, Liguori M, Tran D, Chitnis T, Glanz B, Wolfish C, Gauthier S, Buckle G, Houtchens M, Stazzone L, Khoury S, Hartzmann R, Fernandez-Vina M, Hafler DA, Weiner HL, et al. HLA B*44: protective effects in MS susceptibility and MRI outcome measures. Neurology. 75: 634-40. PMID 20713950 DOI: 10.1212/Wnl.0B013E3181Ed9C9C |
0.411 |
|
| 2010 |
Kuntz NL, Chabas D, Weinstock-Guttman B, Chitnis T, Yeh EA, Krupp L, Ness J, Rodriguez M, Waubant E. Treatment of multiple sclerosis in children and adolescents. Expert Opinion On Pharmacotherapy. 11: 505-20. PMID 20163265 DOI: 10.1517/14656560903527218 |
0.41 |
|
| 2010 |
Liu Y, Bando Y, Vargas-Lowy D, Elyaman W, Khoury SJ, Huang T, Reif K, Chitnis T. CD200R1 agonist attenuates mechanisms of chronic disease in a murine model of multiple sclerosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 2025-38. PMID 20147531 DOI: 10.1523/Jneurosci.4272-09.2010 |
0.366 |
|
| 2010 |
Chabas D, Ness J, Belman A, Yeh EA, Kuntz N, Gorman MP, Strober JB, De Kouchkovsky I, McCulloch C, Chitnis T, Rodriguez M, Weinstock-Guttman B, Krupp LB, Waubant E. Younger children with MS have a distinct CSF inflammatory profile at disease onset. Neurology. 74: 399-405. PMID 20124205 DOI: 10.1212/Wnl.0B013E3181Ce5Db0 |
0.507 |
|
| 2010 |
Vishwas MS, Chitnis T, Pienaar R, Healy BC, Grant PE. Tract-based analysis of callosal, projection, and association pathways in pediatric patients with multiple sclerosis: a preliminary study. Ajnr. American Journal of Neuroradiology. 31: 121-8. PMID 19850763 DOI: 10.3174/Ajnr.A1776 |
0.407 |
|
| 2010 |
Tauhid SS, Moodie J, Neema M, Healy BC, Buckle GJ, Gauthier SA, Glanz BI, Chitnis T, Khoury SJ, Guttmann CR. Abstract #6: Magnetic Resonance Disease Severity Scale (MRDSS) for Patients with Multiple Sclerosis: A Longitudinal Study Neurotherapeutics. 7: 329-330. DOI: 10.1016/J.Nurt.2010.06.008 |
0.378 |
|
| 2009 |
Munger KL, Chitnis T, Ascherio A. Body size and risk of MS in two cohorts of US women. Neurology. 73: 1543-50. PMID 19901245 DOI: 10.1212/Wnl.0B013E3181C0D6E0 |
0.411 |
|
| 2009 |
Yeh EA, Chitnis T, Krupp L, Ness J, Chabas D, Kuntz N, Waubant E. Pediatric multiple sclerosis. Nature Reviews. Neurology. 5: 621-31. PMID 19826402 DOI: 10.1038/Nrneurol.2009.158 |
0.517 |
|
| 2009 |
Sampat MP, Berger AM, Healy BC, Hildenbrand P, Vass J, Meier DS, Chitnis T, Weiner HL, Bakshi R, Guttmann CR. Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal data. Ajnr. American Journal of Neuroradiology. 30: 1731-9. PMID 19696139 DOI: 10.3174/Ajnr.A1659 |
0.398 |
|
| 2009 |
McLaughlin KA, Chitnis T, Newcombe J, Franz B, Kennedy J, McArdel S, Kuhle J, Kappos L, Rostasy K, Pohl D, Gagne D, Ness JM, Tenembaum S, O'Connor KC, Viglietta V, et al. Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. Journal of Immunology (Baltimore, Md. : 1950). 183: 4067-76. PMID 19687098 DOI: 10.4049/Jimmunol.0801888 |
0.474 |
|
| 2009 |
Healy BC, Ali EN, Guttmann CR, Chitnis T, Glanz BI, Buckle G, Houtchens M, Stazzone L, Moodie J, Berger AM, Duan Y, Bakshi R, Khoury S, Weiner H, Ascherio A. Smoking and disease progression in multiple sclerosis. Archives of Neurology. 66: 858-64. PMID 19597087 DOI: 10.1001/Archneurol.2009.122 |
0.471 |
|
| 2009 |
Makhani N, Gorman MP, Branson HM, Stazzone L, Banwell BL, Chitnis T. Cyclophosphamide therapy in pediatric multiple sclerosis. Neurology. 72: 2076-82. PMID 19439723 DOI: 10.1212/Wnl.0B013E3181A8164C |
0.429 |
|
| 2009 |
Gardener H, Munger K, Chitnis T, Spiegelman D, Ascherio A. The relationship between handedness and risk of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 587-92. PMID 19389750 DOI: 10.1177/1352458509102622 |
0.337 |
|
| 2009 |
Gardener H, Munger KL, Chitnis T, Michels KB, Spiegelman D, Ascherio A. Prenatal and perinatal factors and risk of multiple sclerosis. Epidemiology (Cambridge, Mass.). 20: 611-8. PMID 19333127 DOI: 10.1097/Ede.0B013E31819Ed4B9 |
0.361 |
|
| 2009 |
Chitnis T, Glanz B, Jaffin S, Healy B. Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States. Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 627-31. PMID 19299440 DOI: 10.1177/1352458508101933 |
0.501 |
|
| 2009 |
Chitnis T, Pirko I. Sensitivity vs specificity: progress and pitfalls in defining MRI criteria for pediatric MS. Neurology. 72: 952-3. PMID 19289735 DOI: 10.1212/01.Wnl.0000344414.57976.97 |
0.523 |
|
| 2009 |
Stankiewicz JM, Neema M, Alsop DC, Healy BC, Arora A, Buckle GJ, Chitnis T, Guttmann CR, Hackney D, Bakshi R. Spinal cord lesions and clinical status in multiple sclerosis: A 1.5 T and 3 T MRI study. Journal of the Neurological Sciences. 279: 99-105. PMID 19178916 DOI: 10.1016/J.Jns.2008.11.009 |
0.331 |
|
| 2009 |
Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Archives of Neurology. 66: 54-9. PMID 19139299 DOI: 10.1001/Archneurol.2008.505 |
0.493 |
|
| 2008 |
McLaughlin K, Chitnis T, Banwell B, Bar-Or A, Kuhle J, Kappos L, Rostasy K, Pohl D, Wong S, Tavakoli N, Tenembaum S, Franz B, O'Connor K, Hafler D, Wucherpfennig K. F.14. Autoantibodies to Myelin Oligodendrocyte Glycoprotein in Pediatric MS Clinical Immunology. 127: S47-S48. DOI: 10.1016/J.Clim.2008.03.126 |
0.408 |
|
| 2007 |
Chitnis T. The role of CD4 T cells in the pathogenesis of multiple sclerosis. International Review of Neurobiology. 79: 43-72. PMID 17531837 DOI: 10.1016/S0074-7742(07)79003-7 |
0.383 |
|
| 2007 |
Belman AL, Chitnis T, Renoux C, Waubant E. Challenges in the classification of pediatric multiple sclerosis and future directions. Neurology. 68: S70-4. PMID 17438242 DOI: 10.1212/01.Wnl.0000259421.40556.76 |
0.491 |
|
| 2007 |
Pohl D, Waubant E, Banwell B, Chabas D, Chitnis T, Weinstock-Guttman B, Tenembaum S. Treatment of pediatric multiple sclerosis and variants. Neurology. 68: S54-65. PMID 17438239 DOI: 10.1212/01.Wnl.0000259407.40023.Ab |
0.519 |
|
| 2007 |
Tenembaum S, Chitnis T, Ness J, Hahn JS. Acute disseminated encephalomyelitis. Neurology. 68: S23-36. PMID 17438235 DOI: 10.1212/01.wnl.0000259404.51352.7f |
0.348 |
|
| 2007 |
O'Connor KC, McLaughlin KA, De Jager PL, Chitnis T, Bettelli E, Xu C, Robinson WH, Cherry SV, Bar-Or A, Banwell B, Fukaura H, Fukazawa T, Tenembaum S, Wong SJ, Tavakoli NP, et al. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nature Medicine. 13: 211-7. PMID 17237795 DOI: 10.1038/Nm1488 |
0.394 |
|
| 2006 |
Chitnis T. Pediatric multiple sclerosis. The Neurologist. 12: 299-310. PMID 17122726 DOI: 10.1097/01.Nrl.0000250946.87145.Cf |
0.52 |
|
| 2006 |
Kaneko S, Wang J, Kaneko M, Yiu G, Hurrell JM, Chitnis T, Khoury SJ, He Z. Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 9794-804. PMID 16988050 DOI: 10.1523/Jneurosci.2116-06.2006 |
0.349 |
|
| 2006 |
Imitola J, Chitnis T, Khoury SJ. Insights into the molecular pathogenesis of progression in multiple sclerosis: potential implications for future therapies. Archives of Neurology. 63: 25-33. PMID 16401734 DOI: 10.1001/Archneur.63.1.25 |
0.397 |
|
| 2005 |
Imitola J, Chitnis T, Khoury SJ. Cytokines in multiple sclerosis: from bench to bedside. Pharmacology & Therapeutics. 106: 163-77. PMID 15866318 DOI: 10.1016/J.Pharmthera.2004.11.007 |
0.464 |
|
| 2005 |
Chitnis T, Imitola J, Khoury SJ. Therapeutic strategies to prevent neurodegeneration and promote regeneration in multiple sclerosis. Current Drug Targets. Immune, Endocrine and Metabolic Disorders. 5: 11-26. PMID 15777201 DOI: 10.2174/1568008053174804 |
0.496 |
|
| 2003 |
Chitnis T, Khoury SJ. Cytokine shifts and tolerance in experimental autoimmune encephalomyelitis. Immunologic Research. 28: 223-39. PMID 14713716 DOI: 10.1385/Ir:28:3:223 |
0.407 |
|
| 2003 |
O'Connor KC, Chitnis T, Griffin DE, Piyasirisilp S, Bar-Or A, Khoury S, Wucherpfennig KW, Hafler DA. Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions. Journal of Neuroimmunology. 136: 140-8. PMID 12620653 DOI: 10.1016/S0165-5728(03)00002-X |
0.423 |
|
| 2003 |
Chitnis T, Khoury SJ. 20. Immunologic neuromuscular disorders. The Journal of Allergy and Clinical Immunology. 111: S659-68. PMID 12592311 DOI: 10.1067/Mai.2003.92 |
0.33 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2018 |
Gombolay GY, Chitnis T. Pediatric Neuromyelitis Optica Spectrum Disorders. Current Treatment Options in Neurology. 20: 19. PMID 29721683 DOI: 10.1007/S11940-018-0502-9 |
0.3 |
|
| 2022 |
Ziaei A, Lavery AM, Shao XM, Adams C, Casper TC, Rose J, Candee M, Weinstock-Guttman B, Aaen G, Harris Y, Graves J, Benson L, Gorman M, Rensel M, Mar S, ... ... Chitnis T, et al. Gene-environment interactions increase the risk of pediatric-onset multiple sclerosis associated with ozone pollution. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211069926. PMID 35000467 DOI: 10.1177/13524585211069926 |
0.297 |
|
| 2023 |
Bose G, Healy BC, Saxena S, Saleh F, Paul A, Barro C, Lokhande HA, Polgar-Turcsanyi M, Anderson M, Glanz BI, Guttmann CRG, Bakshi R, Weiner HL, Chitnis T. Early neurofilament light and glial fibrillary acidic protein levels improve predictive models of multiple sclerosis outcomes. Multiple Sclerosis and Related Disorders. 74: 104695. PMID 37060852 DOI: 10.1016/j.msard.2023.104695 |
0.295 |
|
| 2023 |
Palotai M, Pintye D, Glanz B, Chitnis T, Guttmann CRG. Fronto-striatal damage may contribute to resistance to fatigue-lowering medications in multiple sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 36746670 DOI: 10.1111/jon.13082 |
0.295 |
|
| 2001 |
Chitnis T, Najafian N, Benou C, Salama AD, Grusby MJ, Sayegh MH, Khoury SJ. Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. The Journal of Clinical Investigation. 108: 739-47. PMID 11544280 DOI: 10.1172/Jci12563 |
0.294 |
|
| 2023 |
Healy BC, Liu Y, Winston-Khan S, Weiner HL, Chitnis T, Glanz BI. Association between PROMIS10, SF-36 and NeuroQoL in persons with multiple sclerosis. Multiple Sclerosis and Related Disorders. 79: 105003. PMID 37741027 DOI: 10.1016/j.msard.2023.105003 |
0.294 |
|
| 2022 |
Gaudioso CM, Mar S, Casper TC, Codden R, Nguyen A, Aaen G, Benson L, Chitnis T, Francisco C, Gorman MP, Goyal MS, Graves J, Greenberg BM, Hart J, Krupp L, et al. MOG and AQP4 antibodies among children with multiple sclerosis and controls. Annals of Neurology. PMID 36088544 DOI: 10.1002/ana.26502 |
0.293 |
|
| 2012 |
Chitnis T, Hollmann TJ. CADASIL mutation and Balo concentric sclerosis: a link between demyelination and ischemia? Neurology. 78: 221-3. PMID 22218279 DOI: 10.1212/Wnl.0B013E31823Fcd3C |
0.291 |
|
| 2011 |
Imitola J, Côté D, Rasmussen S, Xie XS, Liu Y, Chitnis T, Sidman RL, Lin CP, Khoury SJ. Multimodal coherent anti-Stokes Raman scattering microscopy reveals microglia-associated myelin and axonal dysfunction in multiple sclerosis-like lesions in mice. Journal of Biomedical Optics. 16: 021109. PMID 21361672 DOI: 10.1117/1.3533312 |
0.29 |
|
| 2003 |
Chitnis T, Khoury SJ. Role of costimulatory pathways in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis. The Journal of Allergy and Clinical Immunology. 112: 837-49; quiz 850. PMID 14610467 DOI: 10.1016/J.Jaci.2003.08.025 |
0.29 |
|
| 2020 |
Whittam DH, Cobo-Calvo A, Lopez-Chiriboga AS, Pardo S, Gornall M, Cicconi S, Brandt A, Berek K, Berger T, Jelcic I, Gombolay G, Oliveira LM, Callegaro D, Kaneko K, Misu T, ... ... Chitnis T, et al. Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients. Multiple Sclerosis and Related Disorders. 44: 102251. PMID 32629363 DOI: 10.1016/J.Msard.2020.102251 |
0.288 |
|
| 2019 |
Cook LJ, Rose JW, Alvey JS, Jolley AM, Kuhn R, Marron B, Pederson M, Enriquez R, Yearley J, McKechnie S, Han MH, Tomczak AJ, Levy M, Mealy MA, Coleman J, ... ... Chitnis T, et al. Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD. Neurology(R) Neuroimmunology & Neuroinflammation. 6: e583. PMID 31355319 DOI: 10.1212/Nxi.0000000000000583 |
0.288 |
|
| 2021 |
Horton MK, McCauley K, Fadrosh D, Fujimura K, Graves J, Ness J, Wheeler Y, Gorman MP, Benson LA, Weinstock-Guttman B, Waldman A, Rodriguez M, Tillema JM, Krupp L, Belman A, ... ... Chitnis T, et al. Gut microbiome is associated with multiple sclerosis activity in children. Annals of Clinical and Translational Neurology. PMID 34409759 DOI: 10.1002/acn3.51441 |
0.288 |
|
| 2010 |
Apter JT, Fox RJ, Cronin T, Lin J, Sakaie K, Ontaneda D, Mahmoud SY, Lowe MJ, Phillips MD, Wang X, Goldberg-Zimring D, Chavarro-Nieto CD, Healy BC, Achiron A, Warfield SK, ... ... Chitnis T, et al. Abstracts from the ASENT 2010 annual meeting March 4–6, 2010 Neurotherapeutics. 7: 328-333. DOI: 10.1016/J.Nurt.2010.06.003 |
0.287 |
|
| 2000 |
Issazadeh S, Abdallah K, Chitnis T, Chandraker A, Wells AD, Turka LA, Sayegh MH, Khoury SJ. Role of passive T-cell death in chronic experimental autoimmune encephalomyelitis. The Journal of Clinical Investigation. 105: 1109-16. PMID 10772655 DOI: 10.1172/Jci8607 |
0.286 |
|
| 2020 |
Sotiropoulos MG, Chitnis T. Opposing and potentially antagonistic effects of BMP and TGF-β in multiple sclerosis: The "Yin and Yang" of neuro-immune Signaling. Journal of Neuroimmunology. 347: 577358. PMID 32795734 DOI: 10.1016/J.Jneuroim.2020.577358 |
0.286 |
|
| 2020 |
Freedman ME, Healy BC, Huffman JC, Chitnis T, Weiner HL, Glanz BI. A Phase 1 Randomized Controlled Trial of an At-Home Positive Psychology Intervention for Individuals with Multiple Sclerosis International Journal of Ms Care. DOI: 10.7224/1537-2073.2020-020 |
0.286 |
|
| 2007 |
Chitnis T, Imitola J, Wang Y, Elyaman W, Chawla P, Sharuk M, Raddassi K, Bronson RT, Khoury SJ. Elevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegeneration. The American Journal of Pathology. 170: 1695-712. PMID 17456775 DOI: 10.2353/Ajpath.2007.060677 |
0.284 |
|
| 2023 |
Molazadeh N, Akaishi T, Bose G, Nishiyama S, Chitnis T, Levy M. Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis. Multiple Sclerosis and Related Disorders. 80: 105093. PMID 37949025 DOI: 10.1016/j.msard.2023.105093 |
0.284 |
|
| 2001 |
Chitnis T, Najafian N, Abdallah KA, Dong V, Yagita H, Sayegh MH, Khoury SJ. CD28-independent induction of experimental autoimmune encephalomyelitis. The Journal of Clinical Investigation. 107: 575-83. PMID 11238558 DOI: 10.1172/Jci11220 |
0.283 |
|
| 2018 |
Chitnis T, Seifer G, Ghezzi A, Laflamme A, Meinert R, Häring D, Pohl D. Effect of Age on Clinical Outcomes in Patients Treated with Fingolimod: Pooled Analysis of Real-world Phase IV Studies Multiple Sclerosis and Related Disorders. 26: 255. DOI: 10.1016/J.Msard.2018.10.079 |
0.283 |
|
| 2023 |
Chitnis T, Foley J, Ionete C, El Ayoubi NK, Saxena S, Gaitan-Walsh P, Lokhande H, Paul A, Saleh F, Weiner H, Qureshi F, Becich MJ, da Costa FR, Gehman VM, Zhang F, et al. Clinical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis. Clinical Immunology (Orlando, Fla.). 109688. PMID 37414379 DOI: 10.1016/j.clim.2023.109688 |
0.28 |
|
| 2024 |
Varghese JF, Kaskow BJ, von Glehn F, Case J, Li Z, Julé AM, Berdan E, Ho Sui SJ, Hu Y, Krishnan R, Chitnis T, Kuchroo VK, Weiner HL, Baecher-Allan CM. Human regulatory memory B cells defined by expression of TIM-1 and TIGIT are dysfunctional in multiple sclerosis. Frontiers in Immunology. 15: 1360219. PMID 38745667 DOI: 10.3389/fimmu.2024.1360219 |
0.28 |
|
| 2023 |
Corbali O, Chitnis T. Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease. Frontiers in Neurology. 14: 1137998. PMID 36925938 DOI: 10.3389/fneur.2023.1137998 |
0.28 |
|
| 2021 |
Marignier R, Hacohen Y, Cobo-Calvo A, Pröbstel AK, Aktas O, Alexopoulos H, Amato MP, Asgari N, Banwell B, Bennett J, Brilot F, Capobianco M, Chitnis T, Ciccarelli O, Deiva K, et al. Myelin-oligodendrocyte glycoprotein antibody-associated disease. The Lancet. Neurology. 20: 762-772. PMID 34418402 DOI: 10.1016/S1474-4422(21)00218-0 |
0.279 |
|
| 2019 |
Rosso M, Kimbrough DJ, Gonzalez CT, Glanz BI, Healy BC, Rocca MA, Filippi M, Weiner H, Chitnis T. Cross-sectional study of smoking exposure: no differential effect on OCT metrics in a cohort of MS patients. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 5: 2055217319828400. PMID 30828461 DOI: 10.1177/2055217319828400 |
0.278 |
|
| 2016 |
Davoudi V, Keyhanian K, Bove RM, Chitnis T. Immunology of neuromyelitis optica during pregnancy. Neurology(R) Neuroimmunology & Neuroinflammation. 3: e288. PMID 27761482 DOI: 10.1212/Nxi.0000000000000288 |
0.278 |
|
| 2015 |
Kremer S, Renard F, Achard S, Lana-Peixoto MA, Palace J, Asgari N, Klawiter EC, Tenembaum SN, Banwell B, Greenberg BM, Bennett JL, Levy M, Villoslada P, Saiz A, Fujihara K, ... ... Chitnis T, et al. Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder. Jama Neurology. 72: 815-22. PMID 26010909 DOI: 10.1001/Jamaneurol.2015.0248 |
0.276 |
|
| 2022 |
Gonzalez-Martinez A, Bose G, Chitnis T. Anti-CGRP therapies for migraine in multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221096353. PMID 35575242 DOI: 10.1177/13524585221096353 |
0.276 |
|
| 2023 |
Conway S, Saxena S, Baecher-Allan C, Krishnan R, Houtchens M, Glanz B, Saraceno TJ, Polgar-Turcsanyi M, Bose G, Bakshi R, Bhattacharyya S, Galetta K, Kaplan T, Severson C, Singhal T, ... ... Chitnis T, et al. Preserved T cell but attenuated antibody response in MS patients on fingolimod and ocrelizumab following 2nd and 3rd SARS-CoV-2 mRNA vaccine. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 9: 20552173231165196. PMID 37057191 DOI: 10.1177/20552173231165196 |
0.275 |
|
| 2018 |
Healy BC, Glanz BI, Zurawski JD, Mazzola M, Chitnis T, Weiner HL. Long-term follow-up for multiple sclerosis patients initially treated with interferon-beta and glatiramer acetate. Journal of the Neurological Sciences. 394: 127-131. PMID 30248571 DOI: 10.1016/J.Jns.2018.09.020 |
0.273 |
|
| 2017 |
Kim G, Chitnis T. Child Neurology: Primary angiitis of the CNS. Neurology. 89: e268-e271. PMID 29203535 DOI: 10.1212/Wnl.0000000000004718 |
0.273 |
|
| 2011 |
Gross R, Healy BC, Cepok S, Chitnis T, Khoury SJ, Hemmer B, Weiner HL, Hafler DA, De Jager PL. Population structure and HLA DRB1 1501 in the response of subjects with multiple sclerosis to first-line treatments. Journal of Neuroimmunology. 233: 168-74. PMID 21115201 DOI: 10.1016/J.Jneuroim.2010.10.038 |
0.27 |
|
| 2020 |
Bartz D, Chitnis T, Kaiser UB, Rich-Edwards JW, Rexrode KM, Pennell PB, Goldstein JM, O'Neal MA, LeBoff M, Behn M, Seely EW, Joffe H, Manson JE. Clinical Advances in Sex- and Gender-Informed Medicine to Improve the Health of All: A Review. Jama Internal Medicine. PMID 32040165 DOI: 10.1001/Jamainternmed.2019.7194 |
0.27 |
|
| 2017 |
Bove R, Elsone L, Alvarez E, Borisow N, Cortez MM, Mateen FJ, Mealy MA, Mutch K, Tobyne S, Ruprecht K, Buckle G, Levy M, Wingerchuk DM, Paul F, Cross AH, ... ... Chitnis T, et al. Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study. Neurology(R) Neuroimmunology & Neuroinflammation. 4: e339. PMID 28382320 DOI: 10.1212/Nxi.0000000000000339 |
0.269 |
|
| 2014 |
Carruthers RL, Chitnis T, Healy BC. Modeling probability of additional cases of natalizumab-associated JCV sero-negative progressive multifocal leukoencephalopathy. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 757-60. PMID 24189572 DOI: 10.1177/1352458513509509 |
0.269 |
|
| 2004 |
Holsti MA, Chitnis T, Panzo RJ, Bronson RT, Yagita H, Sayegh MH, Tzianabos AO. Regulation of postsurgical fibrosis by the programmed death-1 inhibitory pathway. Journal of Immunology (Baltimore, Md. : 1950). 172: 5774-81. PMID 15100324 DOI: 10.4049/Jimmunol.172.9.5774 |
0.264 |
|
| 2024 |
Rodin RE, Chitnis T. Soluble biomarkers for Neuromyelitis Optica Spectrum Disorders: a mini review. Frontiers in Neurology. 15: 1415535. PMID 38817544 DOI: 10.3389/fneur.2024.1415535 |
0.264 |
|
| 2020 |
Miller AE, Chitnis T, Cohen BA, Costello K, Sicotte NL, Stacom R. Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis: Recommendations of the National Multiple Sclerosis Society. Jama Neurology. PMID 33104165 DOI: 10.1001/jamaneurol.2020.4025 |
0.263 |
|
| 2022 |
Barro C, Healy BC, Saxena S, Glanz BI, Paul A, Polgar-Turcsanyi M, Guttmann CR, Bakshi R, Weiner HL, Chitnis T. Serum NfL but not GFAP predicts cognitive decline in active progressive multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221137697. PMID 36448331 DOI: 10.1177/13524585221137697 |
0.263 |
|
| 2022 |
Chitnis T, Vandercappellen J, King M, Brichetto G. Symptom Interconnectivity in Multiple Sclerosis: A Narrative Review of Potential Underlying Biological Disease Processes. Neurology and Therapy. PMID 35680693 DOI: 10.1007/s40120-022-00368-2 |
0.262 |
|
| 2016 |
Glanz BI, Greeke E, LaRussa A, Stuart F, Rintell DJ, Chitnis T, Healy BC. Risk attitudes and risk perceptions in individuals with multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2: 2055217316665406. PMID 28607735 DOI: 10.1177/2055217316665406 |
0.258 |
|
| 2023 |
Kuhle J, Chitnis T, Banwell B, Tardieu M, Arnold DL, Rawlings AM, Geertsen SS, Lublin AL, Saubadu S, Truffinet P, Kappos L. Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221144742. PMID 36632983 DOI: 10.1177/13524585221144742 |
0.256 |
|
| 2004 |
Chitnis T, Salama AD, Grusby MJ, Sayegh MH, Khoury SJ. Defining Th1 and Th2 immune responses in a reciprocal cytokine environment in vivo. Journal of Immunology (Baltimore, Md. : 1950). 172: 4260-5. PMID 15034039 DOI: 10.4049/Jimmunol.172.7.4260 |
0.256 |
|
| 2024 |
Conway S, Gupta S, Healy B, Chuang TY, Stazzone L, Sullivan J, Polgar-Turcsanyi M, Chitnis T, Houtchens M. Tixagevimab/Cilgavimab does not prevent COVID-19 in patients with multiple sclerosis and related disorders on B-cell depleting therapies. Multiple Sclerosis and Related Disorders. 87: 105680. PMID 38795595 DOI: 10.1016/j.msard.2024.105680 |
0.255 |
|
| 2008 |
Elyaman W, Kivisäkk P, Reddy J, Chitnis T, Raddassi K, Imitola J, Bradshaw E, Kuchroo VK, Yagita H, Sayegh MH, Khoury SJ. Distinct functions of autoreactive memory and effector CD4+ T cells in experimental autoimmune encephalomyelitis. The American Journal of Pathology. 173: 411-22. PMID 18583313 DOI: 10.2353/Ajpath.2008.080142 |
0.251 |
|
| 2017 |
Bradshaw MJ, Vu N, Hunley TE, Chitnis T. Child Neurology: Neuromyelitis optica spectrum disorders. Neurology. 88: e10-e13. PMID 28069981 DOI: 10.1212/Wnl.0000000000003495 |
0.25 |
|
| 2021 |
Chu DT, Rosso M, Gonzalez CT, Saxena S, Healy BC, Weiner HL, Chitnis T. Obesity is associated with the Optic Neuritis severity in Male patients with Multiple Sclerosis. Multiple Sclerosis and Related Disorders. 51: 102910. PMID 33799288 DOI: 10.1016/j.msard.2021.102910 |
0.249 |
|
| 2024 |
Chitnis T, Banwell B, Kappos L, Arnold DL, Gücüyener K, Deiva K, Saubadu S, Hu W, Benamor M, Le-Halpere A, Truffinet P, Tardieu M. Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label extension of TERIKIDS. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585241242050. PMID 38619037 DOI: 10.1177/13524585241242050 |
0.248 |
|
| 2019 |
Santoro JD, Chitnis T. Strokelike Episodes in a Patient With Chronic Gait Abnormalities. Jama Neurology. PMID 30801629 DOI: 10.1001/Jamaneurol.2019.0057 |
0.247 |
|
| 2017 |
Klawiter EC, Bove R, Elsone L, Alvarez E, Borisow N, Cortez M, Mateen F, Mealy MA, Sorum J, Mutch K, Tobyne SM, Ruprecht K, Buckle G, Levy M, Wingerchuk D, ... ... Chitnis T, et al. High risk of postpartum relapses in neuromyelitis optica spectrum disorder. Neurology. PMID 29093070 DOI: 10.1212/Wnl.0000000000004681 |
0.246 |
|
| 2024 |
Virupakshaiah A, Schoeps VA, Race J, Waltz M, Sharayah S, Nasr Z, Moseley CE, Zamvil SS, Gaudioso C, Schuette A, Casper TC, Rose J, Flanagan EP, Rodriguez M, Tillema JM, ... Chitnis T, et al. Predictors of a relapsing course in myelin oligodendrocyte glycoprotein antibody-associated disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 38964848 DOI: 10.1136/jnnp-2024-333464 |
0.246 |
|
| 2003 |
Salama AD, Chitnis T, Imitola J, Ansari MJ, Akiba H, Tushima F, Azuma M, Yagita H, Sayegh MH, Khoury SJ. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. The Journal of Experimental Medicine. 198: 71-8. PMID 12847138 DOI: 10.1084/Jem.20022119 |
0.246 |
|
| 2009 |
Wang Y, Evans JT, Rodriguez F, Fields P, Mueller C, Chitnis T, Khoury SJ, Bynoe MS. A tale of two STAT6 knock out mice in the induction of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 206: 76-85. PMID 19100630 DOI: 10.1016/J.Jneuroim.2008.11.003 |
0.244 |
|
| 2016 |
Barra ME, Soni D, Vo KH, Chitnis T, Stankiewicz JM. Experience with long-term rituximab use in a multiple sclerosis clinic. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2: 2055217316672100. PMID 28607739 DOI: 10.1177/2055217316672100 |
0.243 |
|
| 2022 |
Manzano GS, Holroyd KB, Kaplan T, Bhattacharyya S, Chitnis T, Hotan G, Zurawski J, Galetta KM, Mateen FJ. Disease modifying therapy management of multiple sclerosis after stem cell therapies: A retrospective case series. Multiple Sclerosis and Related Disorders. 63: 103861. PMID 35576727 DOI: 10.1016/j.msard.2022.103861 |
0.242 |
|
| 2022 |
Hanson G, Chitnis T, Williams MJ, Gan RW, Julian L, Mace K, Chia J, Wormser D, Martinec M, Astorino T, Leviner N, Maung P, Jan A, Belendiuk K. Generating real-world data from health records: design of a patient-centric study in multiple sclerosis using a commercial health records platform. Jamia Open. 5: ooab110. PMID 35155999 DOI: 10.1093/jamiaopen/ooab110 |
0.242 |
|
| 2021 |
McAdams M, Stankiewicz JM, Weiner HL, Chitnis T. Review of Phase III Clinical Trials Outcomes in Patients with Secondary Progressive Multiple Sclerosis. Multiple Sclerosis and Related Disorders. 54: 103086. PMID 34289435 DOI: 10.1016/j.msard.2021.103086 |
0.242 |
|
| 2023 |
Santoro JD, Beukelman T, Hemingway C, Hokkanen SRK, Tennigkeit F, Chitnis T. Attack phenotypes and disease course in pediatric MOGAD. Annals of Clinical and Translational Neurology. PMID 37000895 DOI: 10.1002/acn3.51759 |
0.24 |
|
| 2015 |
Melamed E, Levy M, Waters PJ, Sato DK, Bennett JL, John GR, Hooper DC, Saiz A, Bar-Or A, Kim HJ, Pandit L, Leite MI, Asgari N, Kissani N, Hintzen R, ... ... Chitnis T, et al. Update on biomarkers in neuromyelitis optica. Neurology® Neuroimmunology & Neuroinflammation. 2: e134. PMID 26236760 DOI: 10.1212/Nxi.0000000000000134 |
0.237 |
|
| 2020 |
Moreira Ferreira VF, Caefer D, Erlich-Malona N, Healy BC, Chitnis T, Stankiewicz JM. Teriflunomide Safety and Efficacy in Advanced Progressive Multiple Sclerosis. Multiple Sclerosis International. 2020: 5471987. PMID 33381316 DOI: 10.1155/2020/5471987 |
0.237 |
|
| 2014 |
Graves J, Grandhe S, Weinfurtner K, Krupp L, Belman A, Chitnis T, Ness J, Weinstock-Guttman B, Gorman M, Patterson M, Rodriguez M, Lotze T, Aaen G, Mowry EM, Rose JW, et al. Protective environmental factors for neuromyelitis optica. Neurology. 83: 1923-9. PMID 25339213 DOI: 10.1212/Wnl.0000000000001001 |
0.237 |
|
| 2019 |
Rezende RM, Nakagaki BN, Moreira TG, Lopes JR, Kuhn C, Tatematsu BK, Boulenouar S, Maghzi AH, Rubino S, Menezes GB, Chitnis T, Weiner HL. γδ T Cell-Secreted XCL1 Mediates Anti-CD3-Induced Oral Tolerance. Journal of Immunology (Baltimore, Md. : 1950). PMID 31578268 DOI: 10.4049/Jimmunol.1900784 |
0.236 |
|
| 2022 |
Ndayisaba A, Pitaro AT, Willett AS, Jones KA, de Gusmao CM, Olsen AL, Kim J, Rissanen E, Woods JK, Srinivasan SR, Nagy A, Nagy A, Mesidor M, Cicero S, Patel V, ... ... Chitnis T, et al. Clinical Trial-Ready Patient Cohorts for Multiple System Atrophy: Coupling Biospecimen and iPSC Banking to Longitudinal Deep-Phenotyping. Cerebellum (London, England). PMID 36190676 DOI: 10.1007/s12311-022-01471-8 |
0.234 |
|
| 2019 |
Schubert RD, Hawes IA, Ramachandran PS, Ramesh A, Crawford ED, Pak JE, Wu W, Cheung CK, O'Donovan BD, Tato CM, Lyden A, Tan M, Sit R, Sowa GA, Sample HA, ... ... Chitnis T, et al. Pan-viral serology implicates enteroviruses in acute flaccid myelitis. Nature Medicine. PMID 31636453 DOI: 10.1038/S41591-019-0613-1 |
0.234 |
|
| 2002 |
Chung DR, Chitnis T, Panzo RJ, Kasper DL, Sayegh MH, Tzianabos AO. CD4+ T cells regulate surgical and postinfectious adhesion formation. The Journal of Experimental Medicine. 195: 1471-8. PMID 12045245 DOI: 10.1084/Jem.20020028 |
0.232 |
|
| 2013 |
Chitnis T. Pediatric demyelinating diseases. Continuum (Minneapolis, Minn.). 19: 1023-45. PMID 23917099 DOI: 10.1212/01.CON.0000433285.84973.43 |
0.231 |
|
| 2023 |
Kletenik I, Cohen AL, Glanz BI, Ferguson MA, Tauhid S, Li J, Drew W, Polgar-Turcsanyi M, Palotai M, Siddiqi SH, Marshall GA, Chitnis T, Guttmann CRG, Bakshi R, Fox MD. Multiple sclerosis lesions that impair memory map to a connected memory circuit. Journal of Neurology. PMID 37532802 DOI: 10.1007/s00415-023-11907-8 |
0.229 |
|
| 2023 |
Gambrah-Lyles C, Kannan V, Lotze T, Abrams A, Schreiner T, Rodriguez M, Casper TC, Rose JW, Gorman MP, Chitnis T, Loud S, Wheeler Y, Mar S. Assessing Needs and Perceptions of Research Participation in Pediatric-Onset Multiple Sclerosis: A Multistakeholder Survey. Pediatric Neurology. 151: 115-120. PMID 38154238 DOI: 10.1016/j.pediatrneurol.2023.11.019 |
0.228 |
|
| 2021 |
Freedman ME, Healy BC, Huffman JC, Chitnis T, Weiner HL, Glanz BI. An At-home Positive Psychology Intervention for Individuals with Multiple Sclerosis: A Phase 1 Randomized Controlled Trial. International Journal of Ms Care. 23: 128-134. PMID 34177385 DOI: 10.7224/1537-2073.2020-020 |
0.227 |
|
| 2024 |
Wilson E, Meeks HD, Barney BJ, Waltz M, Canenguez K, Casper TC, Rose JW, Rodriguez M, Tillema JM, Chitnis T, Gorman MP, Rensel M, Abrams AW, Krupp LB, Lotze TE, et al. Epidemiology and Impact of Social Hardships in Children With Multiple Sclerosis in the United States. Neurology. 103: e209991. PMID 39531607 DOI: 10.1212/WNL.0000000000209991 |
0.226 |
|
| 2003 |
Murphy B, Yu J, Jiao Q, Lin M, Chitnis T, Sayegh MH. A novel mechanism for the immunomodulatory functions of class II MHC-derived peptides. Journal of the American Society of Nephrology : Jasn. 14: 1053-65. PMID 12660341 DOI: 10.1097/01.Asn.0000057541.69641.F8 |
0.225 |
|
| 2020 |
Rosso M, Saxena S, Chitnis T. Targeting IL-6 receptor in the treatment of neuromyelitis optica spectrum: a review of emerging treatment options. Expert Review of Neurotherapeutics. PMID 32306778 DOI: 10.1080/14737175.2020.1757434 |
0.224 |
|
| 2023 |
Schreiner T, Wilson-Murphy M, Mendelt-Tillema J, Waltz M, Codden R, Benson L, Gorman M, Goyal M, Krupp L, Lotze T, Mar S, Ness J, Rensel M, Roalstad S, Rodriguez M, ... ... Chitnis T, et al. Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231151948. PMID 36960480 DOI: 10.1177/13524585231151948 |
0.223 |
|
| 2020 |
Zhao Y, Wang T, Bove R, Cree B, Henry R, Lokhande H, Polgar-Turcsanyi M, Anderson M, Bakshi R, Weiner HL, Chitnis T. Author Correction: Ensemble learning predicts multiple sclerosis disease course in the SUMMIT study. Npj Digital Medicine. 3: 155. PMID 33299133 DOI: 10.1038/s41746-020-00361-9 |
0.222 |
|
| 2011 |
Chitnis T, Khoury SJ. T-cell-based therapies for multiple sclerosis Multiple Sclerosis Therapeutics, Fourth Edition. 472-482. DOI: 10.1017/CBO9781139023986.044 |
0.221 |
|
| 2003 |
Najafian N, Chitnis T, Salama AD, Zhu B, Benou C, Yuan X, Clarkson MR, Sayegh MH, Khoury SJ. Regulatory functions of CD8+CD28- T cells in an autoimmune disease model. The Journal of Clinical Investigation. 112: 1037-48. PMID 14523041 DOI: 10.1172/Jci17935 |
0.22 |
|
| 2023 |
Bhise V, Waltz M, Casper TC, Aaen G, Benson L, Chitnis T, Gorman M, Goyal MS, Wheeler Y, Lotze T, Mar S, Rensel M, Abrams A, Rodriguez M, Rose J, et al. Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort. Multiple Sclerosis and Related Disorders. 71: 104573. PMID 36871372 DOI: 10.1016/j.msard.2023.104573 |
0.219 |
|
| 2019 |
Boesen MS, Langkilde A, Born AP, Magyari M, Blinkenberg M, Chitnis T, Thygesen LC, Eriksson F. School performance and psychiatric morbidity 6 years after pediatric acute disseminated encephalomyelitis: A nationwide population-based cohort study. Multiple Sclerosis and Related Disorders. 36: 101425. PMID 31655433 DOI: 10.1016/J.Msard.2019.101425 |
0.215 |
|
| 2023 |
Bose G, Healy BC, Barro C, Moreira Ferreira VF, Saxena S, Glanz BI, Lokhande HA, Polgar-Turcsanyi M, Bakshi R, Weiner HL, Chitnis T. Accuracy of serum neurofilament light to identify contrast-enhancing lesions in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 29: 1418-1427. PMID 37712409 DOI: 10.1177/13524585231198751 |
0.215 |
|
| 2006 |
Zhu B, Guleria I, Khosroshahi A, Chitnis T, Imitola J, Azuma M, Yagita H, Sayegh MH, Khoury SJ. Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 176: 3480-9. PMID 16517716 DOI: 10.4049/Jimmunol.176.6.3480 |
0.213 |
|
| 2023 |
Nasr Z, Schoeps VA, Ziaei A, Virupakshaiah A, Adams C, Casper TC, Waltz M, Rose J, Rodriguez M, Tillema JM, Chitnis T, Graves JS, Benson L, Rensel M, Krupp L, et al. Gene-environment interactions increase the risk of paediatric-onset multiple sclerosis associated with household chemical exposures. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 36725329 DOI: 10.1136/jnnp-2022-330713 |
0.212 |
|
| 2024 |
Molazadeh N, Bilodeau PA, Salky R, Bose G, Lotan I, Romanow G, Anderson MR, Matiello M, Chitnis T, Levy M. Predictors of relapsing disease course following index event in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Journal of the Neurological Sciences. 458: 122909. PMID 38335710 DOI: 10.1016/j.jns.2024.122909 |
0.211 |
|
| 2022 |
Cohen JA, Lublin FD, Lock C, Pelletier D, Chitnis T, Mehra M, Gothelf Y, Aricha R, Lindborg S, Lebovits C, Levy Y, Motamed Khorasani A, Kern R. Evaluation of neurotrophic factor secreting mesenchymal stem cells in progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221122156. PMID 36113170 DOI: 10.1177/13524585221122156 |
0.211 |
|
| 2023 |
Qureshi F, Hu W, Loh L, Patel H, DeGuzman M, Becich M, Costa FRD, Gehman V, Zhang F, Foley J, Chitnis T. Analytical Validation of a Serum-Based Assay for Disease Activity Assessments in Multiple Sclerosis. Proteomics. Clinical Applications. e2200018. PMID 36843211 DOI: 10.1002/prca.202200018 |
0.211 |
|
| 2022 |
Healy BC, Casady EC, Chitnis T, Weiner HL, Glanz BI. Estimating the association between physical activity and health-related quality of life in individuals with multiple sclerosis. Multiple Sclerosis and Related Disorders. 65: 104006. PMID 35816952 DOI: 10.1016/j.msard.2022.104006 |
0.21 |
|
| 2024 |
O'Donnell E, Schuette A, Waltz M, Aaen G, Benson L, Gorman M, Lotze T, Mar S, Ness J, Rodriguez M, Tillema JM, Schreiner T, Wheeler Y, Casper TC, Chitnis T. Patient and family views on research priorities and design of clinical trials and research studies in pediatric multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585241274580. PMID 39286941 DOI: 10.1177/13524585241274580 |
0.204 |
|
| 2020 |
Ghezzi A, Chitnis T, K-Laflamme A, Meinert R, Häring DA, Pohl D. Correction to: Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing-Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMSII Trials. Neurology and Therapy. PMID 32060877 DOI: 10.1007/s40120-020-00178-4 |
0.203 |
|
| 2003 |
Ansari MJ, Salama AD, Chitnis T, Smith RN, Yagita H, Akiba H, Yamazaki T, Azuma M, Iwai H, Khoury SJ, Auchincloss H, Sayegh MH. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. The Journal of Experimental Medicine. 198: 63-9. PMID 12847137 DOI: 10.1084/Jem.20022125 |
0.203 |
|
| 2022 |
Manzano GS, Salky R, Mateen FJ, Klawiter EC, Chitnis T, Levy M, Matiello M. Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort. Frontiers in Neurology. 13: 947630. PMID 35795797 DOI: 10.3389/fneur.2022.947630 |
0.203 |
|
| 2024 |
Bilodeau PA, Vishnevetsky A, Molazadeh N, Lotan I, Anderson M, Romanow G, Salky R, Healy BC, Matiello M, Chitnis T, Levy M. Effectiveness of immunotherapies in relapsing myelin oligodendrocyte glycoprotein antibody-associated disease. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585241226830. PMID 38314479 DOI: 10.1177/13524585241226830 |
0.2 |
|
| 2000 |
Kishimoto K, Chitnis T, Khoury SJ, Li XC, Strom TB, Wells AD, Turka LA, Sayegh MH. PASSIVE T CELL DEATH IS NOT REQUIRED FOR INDUCTION OF TRANSPLANTATION TOLERANCE TO MINOR HISTOCOMPATIBILITY ANTIGENS MISMATCHED ALLOGRAFTS. Transplantation. 69: S147. DOI: 10.1097/00007890-200004271-00134 |
0.2 |
|
| 2022 |
Krupp L, Banwell B, Chitnis T, Deiva K, Gaertner J, Ghezzi A, Huppke P, Waubant E, DeLasHeras V, Azmon A, Karan R. Effect of fingolimod on health-related quality of life in paediatric patients with multiple sclerosis: results from the phase 3 PARADIG Study. Bmj Neurology Open. 4: e000215. PMID 35308898 DOI: 10.1136/bmjno-2021-000215 |
0.198 |
|
| 2013 |
Liu J, Brodley CE, Healy BC, Chitnis T. Removing confounding factors via constraint based clustering: An application to finding homogeneous groups of multiple sclerosis patients Proceedings - 2013 Ieee International Conference On Healthcare Informatics, Ichi 2013. 487-492. DOI: 10.1109/ICHI.2013.75 |
0.195 |
|
| 2015 |
Chua AS, Egorova S, Anderson MC, Polgar-Turcsanyi M, Chitnis T, Weiner HL, Guttmann CRG, Bakshi R, Healy BC. Handling changes in MRI acquisition parameters in modeling whole brain lesion volume and atrophy data in multiple sclerosis subjects: Comparison of linear mixed-effect models Neuroimage: Clinical. 8: 606-610. DOI: 10.1016/j.nicl.2015.06.009 |
0.191 |
|
| 2022 |
Ndayisaba A, Pitaro AT, Willett AS, Jones KA, de Gusmao CM, Olsen AL, Kim J, Rissanen E, Woods JK, Srinivasan SR, Nagy A, Nagy A, Mesidor M, Cicero S, Patel V, ... ... Chitnis T, et al. Correction to: Clinical trial-ready patient cohorts for multiple system atrophy: coupling biospecimen and iPSC banking to longitudinal deep-phenotyping. Cerebellum (London, England). PMID 36456723 DOI: 10.1007/s12311-022-01501-5 |
0.185 |
|
| 2019 |
Chitnis T. Pediatric Central Nervous System Demyelinating Diseases. Continuum (Minneapolis, Minn.). 25: 793-814. PMID 31162317 DOI: 10.1212/CON.0000000000000730 |
0.183 |
|
| 2003 |
Salama AD, Chitnis T, Imitola J, Ansari MJI, Akiba H, Tushima F, Azuma M, Yagita H, Sayegh MH, Khoury SJ. Erratum: (The Journal of Experimemal Medicine (July 7, 2003) 198:1 (71-78)) Journal of Experimental Medicine. 198. DOI: 10.1084/Jem.2003071719871Corr |
0.182 |
|
| 2023 |
Nasr Z, Virupakshaiah A, Schoeps VA, Cherbuin N, Casper TC, Waltz M, Hart J, Rodriguez M, Gorman MP, Benson LA, Chitnis T, Rensel M, Abrams A, Krupp L, Waldman AT, et al. Gene-environment interactions and risk of pediatric-onset multiple sclerosis associated with time spent outdoors. Multiple Sclerosis and Related Disorders. 82: 105351. PMID 38141560 DOI: 10.1016/j.msard.2023.105351 |
0.177 |
|
| 2020 |
Barro C, Chitnis T, Weiner HL. Blood neurofilament light: a critical review of its application to neurologic disease. Annals of Clinical and Translational Neurology. PMID 33146954 DOI: 10.1002/acn3.51234 |
0.174 |
|
| 2020 |
Ratajska A, Glanz BI, Chitnis T, Weiner HL, Healy BC. Social support in multiple sclerosis: Associations with quality of life, depression, and anxiety. Journal of Psychosomatic Research. 138: 110252. PMID 32971435 DOI: 10.1016/j.jpsychores.2020.110252 |
0.173 |
|
| 2022 |
Umeton RP, Waltz M, Aaen GS, Benson L, Gorman M, Goyal M, Graves JS, Harris Y, Krupp L, Lotze TE, Shukla NM, Mar S, Ness J, Rensel M, Schreiner T, ... ... Chitnis T, et al. Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum Disorder. Neurology. PMID 36460473 DOI: 10.1212/WNL.0000000000201625 |
0.17 |
|
| 2023 |
G Moreira T, Gauthier CD, Murphy L, Lanser TB, Paul A, Matos KTF, Mangani D, Izzy S, Rezende RM, Healy BC, Baecher-Allan CM, Chitnis T, Kuchroo V, Weiner HL. Nasal administration of anti-CD3 mAb (Foralumab) downregulates and increases and expression in T cells in subjects with COVID-19. Proceedings of the National Academy of Sciences of the United States of America. 120: e2220272120. PMID 36881624 DOI: 10.1073/pnas.2220272120 |
0.168 |
|
| 2023 |
Safadi AL, Osborne B, Chitnis T, Graves JS, Newsome SD, Zamvil SS, Solomon IH, Shin RK. A 28-Year-Old Woman With Left-Sided Weakness and Atypical MRI Lesions: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurology(R) Neuroimmunology & Neuroinflammation. 10. PMID 37673687 DOI: 10.1212/NXI.0000000000200157 |
0.166 |
|
| 2024 |
Sheth MS, Hale DE, Mcarthur JC, Zamvil SS, Goldman MD, Riley C, Chitnis T. A 79-Year-Old Woman With Worsening Headaches and Pachymeningeal Enhancement: A Case Report From the National Multiple Sclerosis Society Case Conference Proceedings. Neurology(R) Neuroimmunology & Neuroinflammation. 11: e200308. PMID 39190855 DOI: 10.1212/NXI.0000000000200308 |
0.164 |
|
| 2022 |
Fujiwara M, Raheja R, Garo LP, Ajay AK, Kadowaki-Saga R, Karandikar SH, Gabriely G, Krishnan R, Beynon V, Paul A, Patel A, Saxena S, Hu D, Healy BC, Chitnis T, et al. MicroRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance. The Journal of Clinical Investigation. PMID 35298438 DOI: 10.1172/JCI155693 |
0.158 |
|
| 2021 |
Popescu M, Feldman TB, Chitnis T. Interplay Between Endocrine Disruptors and Immunity: Implications for Diseases of Autoreactive Etiology. Frontiers in Pharmacology. 12: 626107. PMID 33833678 DOI: 10.3389/fphar.2021.626107 |
0.153 |
|
| 2019 |
Cook LJ, Rose JW, Alvey JS, Jolley AM, Kuhn R, Marron B, Pederson M, Enriquez R, Yearley J, McKechnie S, Han MH, Tomczak AJ, Levy M, Mealy MA, Coleman J, ... ... Chitnis T, et al. Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD. Neurology(R) Neuroimmunology & Neuroinflammation. 6. PMID 31454765 DOI: 10.1212/NXI.0000000000000583 |
0.149 |
|
| 2022 |
Rissanen E, Carter K, Cicero S, Ficke J, Kijewski M, Park MA, Kijewski J, Stern E, Chitnis T, Silbersweig D, Weiner HL, Kim CK, Lyons J, Klein JP, Bhattacharyya S, et al. Cortical and Subcortical Dysmetabolism Are Dynamic Markers of Clinical Disability and Course in Anti-LGI1 Encephalitis. Neurology(R) Neuroimmunology & Neuroinflammation. 9. PMID 35091466 DOI: 10.1212/NXI.0000000000001136 |
0.125 |
|
| 2024 |
Goldstein JM, Konishi K, Aroner S, Lee H, Remington A, Chitnis T, Buka SL, Hornig M, Tobet SA. Prenatal immune origins of brain aging differ by sex. Molecular Psychiatry. PMID 39567743 DOI: 10.1038/s41380-024-02798-w |
0.121 |
|
| 2024 |
Chitnis T, Arnold DL, Quartier P, Chirieac M, Hu W, Jurgensen S, Havrdova EK. Safety, efficacy, and tolerability of alemtuzumab in pediatric patients with active relapsing-remitting multiple sclerosis: The LemKids study. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585241295554. PMID 39618059 DOI: 10.1177/13524585241295554 |
0.12 |
|
| 2024 |
Schoeps VA, Bhargava P, Virupakshaiah A, Ladakis DC, Moseley C, Chong J, Aaen G, Graves JS, Benson L, Gorman MP, Rensel M, Abrams A, Mar S, Lotze TE, Chitnis T, et al. Distinct plasma lipids predict axonal injury and multiple sclerosis activity. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 39266284 DOI: 10.1136/jnnp-2024-333652 |
0.111 |
|
| 2023 |
Corbali O, Saxena S, Patel R, Lokhande H, Chitnis T. NF-κB and STAT3 activation in CD4 T cells in pediatric MOG antibody-associated disease. Journal of Neuroimmunology. 384: 578197. PMID 37770354 DOI: 10.1016/j.jneuroim.2023.578197 |
0.101 |
|
| 2021 |
Pandit L, Cox LM, Malli C, D'Cunha A, Rooney T, Lokhande H, Willocq V, Saxena S, Chitnis T. is elevated in neuromyelitis optica spectrum disorder in India and shares sequence similarity with AQP4. Neurology(R) Neuroimmunology & Neuroinflammation. 8. PMID 33148687 DOI: 10.1212/NXI.0000000000000907 |
0.1 |
|
| 2023 |
Wilson D, Chan D, Chang L, Mathis R, Verberk I, Montalban X, Comabella M, Fissolo N, Bielekova B, Masvekar R, Chitnis T, Ziemssen T, Akgün K, Blennow K, Zetterberg H, et al. Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury. Clinical Chemistry and Laboratory Medicine. PMID 37702323 DOI: 10.1515/cclm-2023-0518 |
0.08 |
|
| 2021 |
Godfrey D, Stone RT, Lee M, Chitnis T, Santoro JD. Triad of hypovitaminosis A, hyperostosis, and optic neuropathy in males with autism spectrum disorders. Nutritional Neuroscience. 1-7. PMID 33666531 DOI: 10.1080/1028415X.2021.1892252 |
0.078 |
|
| 2003 |
Chung DR, Kasper DL, Panzo RJ, Chitnis T, Grusby MJ, Sayegh MH, Tzianabos AO, Chtinis T. CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. Journal of Immunology (Baltimore, Md. : 1950). 170: 1958-63. PMID 12574364 DOI: 10.4049/Jimmunol.170.4.1958 |
0.076 |
|
| 2019 |
Santoro JD, Filippakis A, Chitnis T. Ketamine use in refractory status epilepticus associated with anti-NMDA receptor antibody encephalitis. Epilepsy & Behavior Reports. 12: 100326. PMID 31453565 DOI: 10.1016/j.ebr.2019.100326 |
0.073 |
|
| 2022 |
Chitnis T, Kaskow BJ, Case J, Hanus K, Li Z, Varghese JF, Healy BC, Gauthier C, Saraceno TJ, Saxena S, Lokhande H, Moreira TG, Zurawski J, Roditi RE, Bergmark RW, et al. Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjects. Frontiers in Immunology. 13: 956907. PMID 36505477 DOI: 10.3389/fimmu.2022.956907 |
0.069 |
|
| 2006 |
Zhu B, Guleria I, Khosroshahi A, Chitnis T, Imitola J, Azuma M, Yagita H, Sayegh MH, Khoury SJ. Differential role of programmed death-1 ligand and programmed death-2 ligand in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis The Journal of Immunology. 176: 5683.3-5683. DOI: 10.4049/jimmunol.176.9.5683-b |
0.056 |
|
| 2021 |
Schubert RD, Hawes IA, Ramachandran PS, Ramesh A, Crawford ED, Pak JE, Wu W, Cheung CK, O'Donovan BD, Tato CM, Lyden A, Tan M, Sit R, Sowa GM, Sample HA, ... ... Chitnis T, et al. Author Correction: Pan-viral serology implicates enteroviruses in acute flaccid myelitis. Nature Medicine. PMID 34548659 DOI: 10.1038/s41591-021-01429-z |
0.024 |
|
| Hide low-probability matches. |